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ABSTRACT
What Role Do Tech Companies’ R&D Expenditures Play in Analysts’ Sales and
Earnings Forecasts?
by
Vijaykumar Gandapodi
August 2016
Committee Chair: Conrad Ciccotello
Major Academic Unit: Executive Doctorate in Business
Many top market capitalization companies are information technology (IT) firms,
including Apple, Google, Microsoft, and Facebook, each of which is valued at more than
$300 billion. Facebook is less than 10 years old and is one of the top 10 companies in the
world in terms of market capitalization. However, technologies change rapidly; website
revenue—which once grew at a brisk rate—has slowed down, while mobile technology
growth is increasing and technology trends are shifting toward cloud hosting and big data
analytics. IT companies that have increased their R&D spending remain leaders
throughout periods of technology change. Companies such as Facebook and Google
have doubled and tripled their profits, respectively over` the past decade. In this dynamic
environment, analysts play a critical role in evaluating IT company financial statements
and estimating company sales and earnings per share (EPS). This study examines how
changes in R&D spending are related to analysts’ sales and earnings estimate revisions.
An analysis of data over a 20-year period shows that analysts typically revise their sales
estimates based on changes in a company’s R&D expenditures. The correlation between
analyst earnings estimates and R&D expenditures, however, varies based on company
size and industry within the IT sector. Analysts play a particularly important role in small
companies, where the correlation between R&D and sales changes is not as high as in
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large companies. Analysts are thus critical to the functioning of capital markets in the IT
sector.
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I

CHAPTER 1: INTRODUCTION

In this research study, I explore whether analysts’ revisions in sales and earnings
per share (EPS) estimates are related to R&D expenditure changes by technology
companies. This issue is of interest to both stock market participants and managers of
these firms. With the rising pressure to create and sustain competitive advantages through
technological innovation, IT companies increasingly depend on the efficient management
of research and development (R&D) activities (Bone & Saxon, 2000). R&D investments
are a critical element of growth in firms (Chan, Martin & Kensinger, 1990). Market
participants use analysts’ forecasts because analysts process and transform the
information contained in financial statements—along with additional information about
the industry, firm strategy, and economy—into future earnings predictions (Wieland,
2011). Analysts’ forecast revisions promote market price discovery (Gleason & Lee,
2003) and market participants react to forecast revisions.
The problem statement for this study is: “What role do technology companies’ R&D
expenditures play in analysts’ sales and earnings forecasts?” This study zeros in on IT
companies, extracting records filtered for that sector (group 45) from the Wharton
Research Data Services (WRDS) Compustat database, with a focus on IT companies that
have R&D expenditures on their balance sheets. I extracted analysts’ forecasts for IT
company sales and EPS for the current and the following year from the Institutional
Brokers' Estimate System (I/B/E/S) database.
This research focuses on companies trading in US exchanges. I categorize companies by
size into small, midsized, and large based on market capitalization. I also examine
various industries within the IT sector; as one study found, R&D intensity that is higher

2
than the particular industry’s average leads to larger stock-price increases for firms in
high-tech industries (Chan, Martin & Kensinger, 1990).
I observe that analysts do change their sales forecasts in response to changes in
R&D expenditures by technology firms. The relation is robust across three different
sectors of the IT industry. Analysts also change their EPS estimates in response to
changes in R&D, although this relation is not as strong when I consider changes in sales.
Interestingly, I find that in the smallest capitalization firms, analysts change EPS
estimates in response to changes in R&D, even when sales changes are considered. I
consider this as evidence of the importance of analysts to capital allocation in the
technology industry.
The findings I captured during my analysis add to the academic research related
to R&D expenditure and analyst estimates. Research spending is heavily concentrated in
technology and science-oriented industries. The computer programming, software, and
services industry represents about 17 percent of the sales and two times the earnings
compared to other companies in these sectors. Other research (Chan, Lakonishok &
Sougiannis, 2001) focuses on R&D, but does not concentrate on the analyst aspect. This
study will benefit practitioners, allowing them to make smarter investments based on
R&D expenditure. Further, analysts’ recommendations on EPS and sales have a
correlation with stock prices. Huo and Hung (2014) show that stock price drift emerges
after analysts’ revise their earnings forecasts.
The study will also benefit managers of technology companies by clarifying how
analysts make revisions. For small firms, analysts play a particularly important role, as
these firms tend to have less market coverage.

3
Analyst forecasts are superior to time-series forecasts because analysts possess
both an information advantage and a timing advantage (Brown, 1987). Keung’s study
(2010) finds that earnings forecast revisions supplemented with sales forecast revisions
have a greater impact on security prices than stand-alone earning forecast revisions. He
further found that financial analysts are more likely to supplement their earnings forecasts
with sales forecasts when they have better information. As Keung’s study discusses in
detail, supplementary sales forecasts appear to lend credibility to earnings forecasts
because financial analysts provide better sales forecasts when they are more informed.
These findings help us understand the characteristics of analysts’ sales and EPS forecasts.
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II

CHAPTER 2: LITERATURE SYNTHESIS

R&D in technology companies is important for several reasons. For example, it
influences executives’ incentives, compensation, and firm performance. Currim, Lim, and
Kim (2012) found the increase in equity-to-bonus compensation ratio for top executives
is positively associated with an increase in R&D spending. Further, in their work on
analyst forecast revisions and market price discovery, Gleason and Lee found a postrevision price drift associated with these forecast revisions (Gleason & Lee, 2003). Also,
changes in R&D expenditure in either direction indicate transitions between exploitative
and exploratory R&D and are associated with increased firm performance (Mudambi &
Swift, 2014). Such examples illustrate the importance of R&D expenditure and how it
impacts top executives’ compensation and the stock price performance of firms.
This association is more intense in high-growth firms and is especially significant
in the high-tech sector (García-Manjón & Romero-Merino 2012). This study further
found that policymakers and business leaders in the high-tech sector maintain R&D
expenditures even when facing a recession. Graham and Frankenberger (2008) report
that increases in R&D spending in recessions increase firm profit and intangible value.
Even during the recession, companies reduce R&D spending to meet their quarterly
results, which in turn impacts the growth of the firm. As this literature synthesis shows,
R&D spending is a key metric for increasing or decreasing firm’s earnings.
R&D is also important to market participants. The study by Kumar,
Charurvedula, Rastogi, and Bang (2009) found that buy recommendations issued by
analysts help investors generate abnormal returns on the day of the recommendation. On
the other hand, sell recommendations do not show significant negative abnormal returns.
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An analyst forecast revision and market price discovery study by Gleason and Lee (2003)
found that post-revision price drift is associated with analyst forecast revisions. That
study documents the following four significant factors:
1. The market does not sufficiently distinguish between revisions that provide new
information and revisions that merely move toward the consensus.
2. The price adjustment process is faster and more complete for celebrity analysts
than for more obscure yet highly accurate analysts.
3. The price adjustment process is faster and more complete for firms with greater
analyst coverage.
4. A substantial portion of the delayed price adjustment occurs around subsequent
earnings-announcement and forecast-revision dates.
The above studies confirm that investors use analyst information for investing in the
stock market. Hillary and Hsu (2013) empirically showed that analysts with a lower
standard deviation of forecast errors have a greater ability to move prices. These results
have three implications:
1. Consistent analysts are less likely to be demoted and more likely to be nominated
as all-star analysts.
2. Analysts strategically deliver downward-biased forecasts to increase their
consistency (sometimes at the expense of stated accuracy).
3. The benefits of consistency and of “lowballing” (accuracy) are to increase (or
decrease) the institutional investor’s presence.
These findings help us understand that analyst reports are used not only by
individual investors, but also by institutional investors.
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Fama and French (1992) also found positive abnormal returns associated with high
Earnings to Price (E/P) stocks, but they found an even stronger relationship between book
value to price (B/P) ratios and abnormal returns. Bauman and Dowen (1988) discovered
mixed results between high growth stocks and stock returns; during their study, they
found long-term, low growth stocks with low P/E had higher return than higher growth
stocks with higher P/E. These studies help us to understand the importance of the EPS;
the Fama and French (1992) study confirms the significance of a company’s earnings for
the share price being traded. This literature synthesis illuminates how the investment
community uses analyst forecast reports.
Analysts offer significantly greater coverage for firms with larger R&D and
advertisement expense relative to their industry, as well as for firms in industries with
large R&D expenses (Barth, Kasniz & McNicholas, 1999). As Figure 1 shows, the US
National Science Foundation offers a reliable source for R&D trends for US companies
and government, with a steady transfer of R&D spending from government to the
business sector.
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Figure 1 U.S. R&D as Percent of Gross Domestic Product, 1953-2008
Source – National Science Foundation, (Hirschey et al. 2012)
Similar to current cash flow, growth, risk, and market share, advertising and R&D
expenditures are key determinants of a firm’s market value (Chauvin & Hirschey 1993).
Chauvin and Hirschey’s also found that the market value effects of advertising and R&D
are broadly operative throughout both manufacturing and nonmanufacturing sectors.
They suggest that advertising and R&D are an attractive alternative means of investment
in valuable intangible capital that have differing degrees of relevance in different
economic sectors.
Sougiannis (1994) found that, on average, a one-dollar increase in R&D leads to a
two-dollar increase in profit over a seven-year period, with a five-dollar increase in

8
market value. Companies with high R&D-to-equity-market value (which tend to have
poor past returns) earn large excess returns (Chan, Lakonishok & Sougiannis, 2001).
Analyst accrual and forecast revision strategies generate returns of 15.5 percent and 5.5
percent, respectively, when implemented independently (Bath & Hutton, 2003). Bath and
Hutton add that a combined strategy that uses forecast revisions to refine the accrual
strategy generates a return of 28.55 percent. They further discuss many studies
pertaining to analyst earnings forecast; some of these studies argue that analysts don’t
account for key accounting data (Stober, 1992; Abarbanell & Bushee, 1997). However,
other studies point out that analyst forecasts are more accurate than time-series models in
predicting future earnings (Brown, Griffin, Hagerman & Zmijewski, 1987). Such
research suggests that analyst forecasts have the potential to give investors value-relevant
information about earnings (Bath & Hutton, 2003).
Bath and Hutton note that a second stream of analyst forecast research focuses on
whether investors actually heed the information in analyst forecast revisions. Numerous
studies (e.g., Givoly & Lakonishok, 1980; DeBondt, 1991; Mendenhall, 1991; Stickel,
1991; Gleason & Lee, 2000; and Elgers, Lo, & Pfeiffer, 2001) have found that analyst
forecast revisions predict future returns, indicating that investors do not fully utilize the
information reflected in the forecasts on a timely basis.
In their study, Hirschey et al. (2012) found that R&D spending continues to grow
faster than advertising and capital expenditures. As Figure 2 shows, they found that IT
companies and small market capitalization companies that spend on R&D increased their
spending by 57 percent between 1976 and 2010, while non-IT sector companies and large
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companies (which constitute most of the NYSE) reduced such spending by 12 percent.
The data in the Figure 2 does not include financial or utilities sector companies.

Figure 2 American Economic Association
(Hirshey et al. 2008)
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Although various studies examine analyst forecasts and R&D, no existing studies
have examined how R&D impacts analysts’ sales and EPS estimates, nor have
researcher’s analyzed segmentation based on company size and industry type. This
information can be very helpful for practitioners as they consider moving their companies
into different industry segments or consider buying the stock of IT companies of different
sizes. This quantitative study will fill this gap and contribute both to practitioners and the
academic literature.
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III CHAPTER 3: THEORETICAL BACKGROUND AND HYPOTHESES
Based on the previous studies in my literature synthesis, it is clear that R&D
spending has an impact on what aspect of high-tech companies. Much existing literature
focuses on analysts and their impact on stock price. Prior studies have shown that
analysts’ estimates of earnings or sales are quite close to the actual sales and earnings of
the company—and hence the market reacts when analysts change their estimates. The
stock’s price moves on the day of an analyst’s revision, especially if that analyst has
maintained a strong reputation over the years in covering that sector. In their study,
Kumar et al. (2009) found that buy recommendations issued by analysts on public
domains help investors generate abnormal returns on the day of the recommendation,
while sell recommendations show no significant negative abnormal returns.
Analysis done through this quantitative study will expand on the earlier studies
and focus on the association between the R&D spending and analysts’ sales and EPS
estimate forecasts. This research will compare the generated results between various
industries within the IT sector. It will also review the impact of R&D change on analysts’
estimate forecasts based on the size of the firms. Practitioners will benefit from the
findings through a better understanding of how analysts modify their estimates for
different industry groupings and company sizes in the IT sector. Further, by
understanding how estimates are reflected in the current year versus the next year,
management can better plan their R&D spending budget to enhance the organization’s
future.
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Hypothesis 1: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the current year.

Research and

Analyst EPS estimate

development year

revision for current year

over year difference
Figure 3 Hypothesis 1

Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the next year.
Research and

Analyst EPS estimate

development year

revision for next year

over year
difference

Figure 4 Hypothesis 2

Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the current year.

Research and
Analyst Sales estimate
development year
revision for current year
over year difference
Figure 5 Hypothesis 3
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Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the following year.
Research and

Analyst Sales

development year

estimate revision for

over year

next year
Figure 6 Hypothesis 4

difference
This study primarily focuses on these four hypotheses, reviewing the correlation
and regression results of R&D year-over-year expenditure differences associated with
analysts’ sales and EPS estimates for the current year and the next year. The difference
between R&D expenditure from the prior to the current year is the independent variable.
Analysts provide sales or EPS estimates for a company for multiple years based on the
information they gather during company earning calls and/or through reports filed by the
company to regulating agencies. The analysts’ sales and EPS estimates for the current
year and the next year are the dependent variables.
III.1 Research and Development Expense (R&D)
According to the Frasacti Manual, “Research and experimental development
(R&D) comprise creative work undertaken on a systematic basis in order to increase the
stock of knowledge, including knowledge of man, culture and society, and the use of this
stock of knowledge to devise new applications” (OECD, 1993).
R&D covers three activities: basic research, applied research, and experimental
development. Basic research is experimental or theoretical work undertaken primarily to
acquire new knowledge of the underlying foundations of phenomena and observable
facts, without any particular application or use in view. Applied research is also an
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original investigation, undertaken to acquire new knowledge. It is, however, directed
primarily toward a specific practical aim or objective. Experimental development is
systematic work, drawing on existing knowledge gained from research and/or practical
experience and directed towards producing new materials, products, and devices;
installing new processes, systems, and services; or improving substantially those already
produced or installed (OECD, 1993).
R&D spending has grown sharply as a percentage of sales. In 1975, R&D
expenditure stood at 1.70 percent, but it more than doubled by 1995 to 3.75 percent
(Chan, Lakonishok & Sougiannis, 2001). R&D expenditure is provided by companies in
their income statement, which I extracted from the WRDS database for this study.
III.2 Current Year EPS Estimate Revision
Current year EPS is defined as the company’s total profit in a fiscal year, divided
by the number of outstanding shares. Analysts gather this information based on the
financial statements, company regulatory filing statements and by interacting with
company management. Agarwal et al. (2012) found that earnings forecasts strongly
respond to macroeconomic releases that signal changes in overall business conditions
after controlling for analysts’ learning from firm and industry-specific earnings surprises.
They also found that medium-term forecasts respond much more strongly to
macroeconomic news than forecasts for the current fiscal year. On average,
macroeconomic surprises lead analysts to revise their current year earnings forecasts for
cyclical firms by three cents and the following year’s forecast by five cents. Such
revisions might be made when the company’s leadership changes, or when the company
faces new competition.
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Analysts develop expertise in obtaining and analyzing information from various sources,
including the following:


Earnings and other information from SEC filings, such as proxy
statements and periodic financial reports



Industry and macroeconomic conditions



Conference calls and other management communications

Using this information, analysts produce earnings forecasts, target price forecasts,
and stock recommendations, along with qualitative reports describing a firm’s prospects.
Ramnath (2002) showed that analysts revise their earnings forecasts in response to the
earnings announcement of other firms in the same industry. Based on the above studies, I
can confirm that analysts include specific industry and/or market sector factors in their
earnings forecasts. EPS is also impacted when there is an increase in advertisement
spending, as it will attract more customers. With additional customers, the firm’s
revenues will rise, which in turn increases the bottom line of the company.
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Figure 7 Input to Analyst Report
(Ramnath, Rock, Shane 2003)
III.3 Next Year EPS Estimate Revision
Next year EPS is defined as the profit a company generates per share in the
following year. Analysts update this estimate at the same frequency as they update their
current year EPS; the factors that impact the current year EPS estimates might also
impact the next year EPS estimates. However, in some scenarios, the current year EPS
might be reduced, while the next year EPS is increased. For example, a company might
spend more on advertising in the current year to market a new product, reducing
advertising in the year following, which will increase the EPS estimate for that following
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year. Also, the next year’s EPS estimate might be revised up, as the resources hired to
support the new product might not be needed in the following year. As the new product
stabilizes, customer support will be reduced, which improves the EPS of the organization.
III.4 Current Year Sales Estimate Revision
The current year sales forecast is defined as the company revenue that analysts
predict for the current year. Analysts’ forecasts and the revisions that follow influence
price-relevant trades (Givoly & Lakonishok, 1979; Lys & Sohn, 1990; Park & Stice,
2000). Analysts’ estimating activities should cause prices to reflect the market and
industry information, resulting in larger return synchronicity (Piotroski & Roulstone
2003). Clement (1999) and Jacob, Lys, and Neale (1999) found that analyst accuracy
improves with industry specialization, while Gilson et al. (2001) illustrated that the
analyst coverage composition is impacted after spin-offs and equity carve-outs.
The macro economy also plays an important part in analysts’ sales estimates. For
example, when consumer confidence falls, people reduce their spending, which impacts a
company’s revenue. Also, when the companies are not hiring and wages stagnate,
consumer spending also declines, which also impacts a company’s sales. When jobs are
impacted, people delay buying computers, software, and other technology products that
impact computer manufacturers and software development companies. The same is true
for corporations: companies review the outlook of the economy and decide on their
spending; if the outlook is bleak, they postpone capital purchase for few years and wait
for market conditions to improve. Corporate analysts thus revise their revenue forecasts
for technology companies based on job market conditions, consumer confidence, and
economic outlook.
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Historically, the technology industry has experienced considerable disruption.
Blackberry—once the leader in the smart phone industry—was replaced by Apple and
Samsung, while Yahoo’s leadership in search engine and email technology was usurped
by Google. Analysts thus look at the industry, review the competition in various areas,
and revise the revenue forecasts for companies accordingly.
III.5 Next Year Sales Estimate Revision
Analysts’ next year sales estimate forecasts are defined as the revenue a company
is expected to make the following year. Analysts update their estimates for the next year
at the same frequency as they update their sales estimate forecasts for the current year, as
factors that impact the current year’s sales might also impact those of the following year.
Similar to EPS, the next year’s sales estimate might differ from the current year’s sales
estimate. New product launches or new marketing initiatives might influence next year’s
revenue, which in turn is captured by analysts when they estimate the next year’s sales.
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IV CHAPTER 4: DATA COLLECTION AND ANALYSIS
For this research, I extracted two sets of data from the WRDS website:


R&D expenditure and company-related information



Analyst estimate information

I extracted the R&D expenditure and company-related information from the
Compustat database. Because my research focuses on the IT sector, I specifically
extracted the data pertaining to this sector by querying the database with Global Industry
Classification (GIC) sector code 45. I gathered the R&D/company-related data from the
yearly database section, which annually consolidates this data for IT companies.
I extracted analyst estimates from the WRDS IBES database for the following categories:


Sales estimate for the current year (“1st year” as per WRDS database)



EPS estimate for the current year



Sales estimate for the next year (“2nd year” as per WRDS database)



EPS estimate for the next year

Most analysts make changes to their estimates following the company’s quarterly
earnings release; analysts attend the quarterly earnings release conference and ask
questions needed to update their forecast estimate. Their questions typically focus on the
existing quarterly results, as well as the company’s forecast in terms of sales, earnings,
expenditure on advertisement, and R&D. This information gives them the input needed to
model their earnings estimate forecasts for sales and EPS. After gathering this
information, analysts generate a detailed report about the target company. In that report,
they cover the company’s future sales, earnings, and ideal stock price, and offer a
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recommendation to buy, sell, or hold the stock. Finally, some analysts change their
estimate forecasts in the wake of macro information or changes related to the company.
Although analysts publish their estimates about a target company on different days in a
month, the IBES database consolidates the information on a monthly basis. Because
multiple analysts cover particular stocks—typically those of large or popular
companies—in a given month, multiple analysts might change their estimates. I thus use
the median information for this study.
The data I collected for R&D expenditures and analyst estimates is for 20 years,
from 1995 to 2014. I extracted the data in Excel format from the Compustat and IBES
databases. I then cleaned the data in the Excel database before loading it into IBM
Statistical Package for Social Sciences (SPSS). I extracted data related to all IT
companies, but not all such companies have R&D expenditures so I filtered out those
companies who did not spend on R&D in the Excel spreadsheet.
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Table 1 R&D and Company-Related Information
Data extracted

Description of the data.

Stock Symbol

Symbol representing the stock, (Apple, symbol will
be AAPL, Microsoft MSFT)

Fiscal year

Financial year (1995, 1996….)

Company Name

Full name of the company, Apple will be Apple
INC, IBM will be INTL BUSINESS MACHINES
CORP

Revenue

Total revenue for the year.

Asset

Total Asset the company reported during end of
their financial year in their reports.

Gross Profit

Profit company makes after deducting the costs
associated with making and selling its products

R&D spending for current year

Research and development spending for the current
year

R&D spending for prior year

Research and development spending for the prior
year

Long-term debt

Debt obligations such as bank loans, mortgage,
bonds which matures more than one year

Notes: R&D information and company-related information from Compustat
database.
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I calculated the following information using the data in Table 1:


Gross margin: gross profit/revenue



The gross margin data point (used during the regression)



Debt-to-sales: long-term debt/revenue



The debt-to-sales data point (used during the regression)



Revenue difference: the revenue for the current year minus the revenue for the
prior year



Revenue difference percentage: revenue difference/revenue for prior year
Because the revenue for the prior year is not available in the WRDS, I derived it

from the previous year’s data using Excel advanced programming.
I generated the second set of data from the IBES database.
Table 2 Analyst Data from IBES
Data extracted from IBES database
Symbol
Period end data
Measurement (EPS or Sales)
Forecast period (1 – current year, 2 – Next year)
Median estimate

I extracted the IBES data pertaining to analyst estimates into Excel as monthly
summary data, then transformed it into analysts’ beginning of the year and end of the
year estimates. I did this using Excel functions and pivot tables. A company’s starting
month and ending month are identified at the start of the data construction process; such
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information varies among companies as they have different fiscal year closing months
(most companies use December as the fiscal year closing month, but some use March,
June, or September).
I used advanced Excel functions to calculate analyst data in four areas—current
year sales percentage, next year sales percentage, current year EPS percentage, and next
year EPS percentage—then merged the data with the records generated from the
Compustat database. The R&D data, company data, and analyst data are normalized into
a single record for each company per calendar year. For example, for IBM, there is one
record per year from 1995 to 2014; this contains all the data needed for my analysis. The
data massaged in Excel is then uploaded and analyzed in SPSS software.
Table 3 Data Calculated and Consolidated in Excel Spread Sheet
Data consolidated in Excel spread sheet
Analyst Sales estimate forecast for current year
Analyst Sales estimate forecast for Next year
Analyst EPS estimate forecast for current year
Analyst EPS estimate forecast for Next year
Analyst Sales estimate forecast percentage change for current year
Analyst Sales estimate forecast percentage change for Next year
Analyst EPS estimate forecast percentage change for current year
Analyst EPS estimate forecast percentage change for Next year

24
IV.1 Distribution of Samples over Time, by Size and by Industry
IV.1.1 Time
The data in Table 4 provides the year-wise breakup of the number of companies
in each calendar year for this study. This research is a 20-year study of IT companies,
with data gathered for the years 1995 to 2014. The records identified are for companies
that had R&D expenses allocated in their balance sheets that were also covered by
analysts. The number of companies in Table 4 for each calendar year increased from
1995 to 1999, then, following dot-com burst, the number declined, as many technology
companies went bankrupt. After the dot-com crash, the market value of many companies
decreased dramatically, and many were either bought by or merged with other (often
larger) companies. In 2000, 526 companies IT companies had R&D allocations on their
income statements and were covered by analysts. In 2013, the number declined to 327—
a reduction of 199 companies over 13 years due to bankruptcy, mergers, or purchase by
other companies. However, the study’s final year (2014) showed a slight increase in IT
companies.
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Table 4 Year Wise Number of Firms

Year
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014

No of
companies
in this
study
Percentage
301
3.8
387
4.9
413
5.2
423
5.4
462
5.8
526
6.7
489
6.2
448
5.7
407
5.2
407
5.2
392
5.0
378
4.8
398
5.0
363
4.6
346
4.4
337
4.3
339
4.3
332
4.2
327
4.1
341
4.3

IV.1.2 Size
Market capitalization data provides company size: the larger the market
capitalization, the larger the company. The firms are divided into three categories
according to their market capitalization:


Large: greater than or equal to $10 billion (USD)



Midsized: greater than $1 billion, but less than $10 billion



Small: less than $1 billion
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I categorize the data to show how analysts capture R&D expenditure changes in
their estimate forecasts. Large companies (greater than $10 billion) are covered by more
analysts; typically those companies have been in business for a long time and have grown
over the years. Small companies (less than $1 billion) are typically newer firms that are
covered by fewer analysts.
IV.1.3 Industry
After extracting data for the IT sector using GIC sector code 45, three industry
groupings emerged as identified by GIC group codes: Software and Services (which had
the most records), Technology Hardware and Equipment, and Semiconductor.
Table 5 Industry Grouping
GIC group code

Description of the group

4510

Software and Services

4520

Technology Hardware and equipment

4530

Semiconductor

IV.1.3.1 Software and Services group
The Software and Services group encompasses application software, systems
software, Internet software and services, data processing and outsourced services, IT
consulting, and home entertainment software companies. As Table 6 shows, this group
had the most records (3,074).
IV.1.3.2 Technology Hardware and Equipment
The Technology Hardware and Equipment group consists primarily of
communications equipment, computer hardware, computer storage and peripherals,
electronic equipment and instruments, electronic components, electronic manufacturing
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services, technology distributors, and office electronics companies. This group had 2,961
records (see Table 6).
IV.1.3.3 Semiconductor
The Semiconductor group is made up of semiconductor and semiconductor
equipment firms, and was once part of the Technology Hardware and Equipment group.
It had the fewest number of records, with 1,863 (Table 6).
Table 6 Number of Records Industry Wide
Type of industry
Software and Services
Technology Hardware and equipment
Semiconductor

No of Records
3074
2961
1863

Percentage
38.9
37.5
23.6

Table 7 shows the industry groupings, sub-industry descriptions, and sample
companies.
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Table 7 Sub Industries and Company Examples.
Industry

Sub Industries description

Examples of
companies in these
industry

Software and Services

Internet Software & Services

Yahoo, AOL,

IT consulting and other services

Teradata, IBM

Data processing and outsourced

Xerox

services

Technology Hardware

Application Software

Intuit, Adobe systems

Systems Software

Oracle, Microsoft

Home Entertainment Software

Take-Two, Zynga

Communications Equipment

Cisco, Qualcom

Computer Hardware

Dell

Computer Storage and Peripherals

Apple, Sandisk

Electronic Equipment and

Itron, Zebra

Instruments

technologies

Electronic Components

Corning

Electronic Manufacturing Services

Flextronics

Technology distributors

Richardson electronics

Office electronics

General Scanning

Semiconductor Equipment

Lam Research,

& equipment

Semiconductor

Teradyne
Semiconductors

Texas Instrument, First
solar

IV.2 Data analysis
A single record for each company per fiscal year was created in Excel and imported into
SPSS to generate the results. Separate results were generated for analysts’ sales
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estimates and analysts’ EPS estimates; to show analysts’ estimate changes for current
year and next year, I ran the tests separately for each of those years.
A summary of the analysis done in SPSS to generate the results is as follows:


Descriptive statistics were generated for all variables used in this study.



A correlation matrix was generated for all independent variables and for
different market capitalization companies.



Correlation tests were performed to identify the association between R&D
spending and the changes in analysts’ current year sales estimates; these tests
were run for the three different industry groups and for the three different
company sizes. A correlation test was also run for R&D spending increases
that were greater than five percent (eight tests were performed in this
category).



Correlation tests were performed to identify the association between R&D
spending and changes in analysts’ next year sales estimates, as well as the
above-mentioned six segment tests and those for R&D spending increases
greater than five percent (eight tests were also performed in this category).



Correlation tests were performed to identify the association between R&D
spending and analysts’ current year EPS estimates, along with the same six
segment tests and those for R&D spending increases greater than five percent
(again, eight tests were performed in this category).



The same correlation tests were performed to identify the association between
R&D spending and changes in analysts’ next year EPS estimates.
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Regression tests were run on five independent variables—R&D spending
differences, revenue differences, assets log, long-term debt/sales, and gross
margin— association with changes in analysts’ current year sales estimates.
As with correlation, regression tests were run for the three industry groups and
three company sizes, as well as for R&D spending increases greater than five
percent. I also ran an additional test without revenue difference regression
(performing nine regression tests in this category).



Regression tests were run on the five independent variables association with
changes in analysts’ next year sales estimates, the six segmentation tests,
R&D greater than 5 percent, and regression without revenue differences (nine
tests).



The same regression tests were performed with the above-mentioned
independent variables association with changes in analysts’ current year EPS
estimates.



The same regression tests were performed with the above-mentioned
independent variables association with changes in analysts’ next year EPS
estimates.

Overall, 32 correlation and 40 regression tests were conducted to analyze the four
different hypotheses in this study. The outcomes of these tests will help to determine
whether the results support the four hypotheses.
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V

CHAPTER 5: RESULTS

V.1 Descriptive Statistics
Table 8 shows summary statistics of data gathered for 7,900 samples related to IT
firms with group ID 45. The variable assets, gross profit (loss), long-term debt, revenue,
gross margin, research and development current year, research and development prior
year, and market value were extracted from the Compustat database. Revenue prior year,
revenue difference, revenue difference percentage, R&D difference, and R&D difference
percentage were calculated.
I extracted analysts’ current and next year EPS estimates from the end and the beginning
of each year from the IBES database. I extracted the same data for analysts’ sales
estimates from IBES. The actual difference and the difference in percentage variables for
EPS and sales were calculated in Excel before uploading the values into SPSS.
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Table 8 Descriptive Statistics
Minimum

Maximum

Mean

Std. Dev

0.03

290479.00

1990.70

10510.24

-719.76

104126.00

756.84

4213.38

0.00

39959.00

232.63

1572.32

Revenue current year

0.00

233715.00

1430.16

7936.83

Revenue Prior year

0.00

182795.00

1518.93

7873.99

Revenue difference

-12519.00

50920.00

114.47

1293.41

-1.00

65.87

0.20

1.14

-141.41

1.00

0.38

3.49

0.60

626550.35

5072.62

28018.82

Research & Development Expense

0.00

12128.00

146.98

675.72

Research & Development Prior year

0.00

11537.00

134.53

629.37

-1595.00

2209.00

12.45

94.22

-1.00

345.84

0.36

4.31

-645.00

53.20

0.00

9.33

-510.00

57.00

0.32

7.04

-318.20

27.75

-0.32

5.00

-116.25

205.00

-0.18

4.75

Assets – Total
Gross Profit (Loss)
Long-term debt
Revenue

Revenue difference percentage
Gross Margin
Market Value - Total - Fiscal
Research & Development

Research spending difference
Research difference percentage
Analyst estimate current year EPS end of
the year
Analyst estimate current year EPS
beginning of the year
Analyst estimate current year EPS
difference
Analyst estimate current year EPS
difference %
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Analyst estimate next year EPS end of the
-141.43

58.50

0.61

3.52

-276.57

75.60

0.84

4.88

-106.41

188.00

-0.23

3.60

-81.00

63.00

-0.20

2.56

0.00

233139.50

1597.31

8441.96

0.00

210730.00

1616.93

8447.77

-22608.30

22409.50

-19.63

780.76

-1.00

14.00

-0.02

0.30

0.00

245433.00

1775.64

9216.57

0.60

224865.00

1844.63

9340.82

-85452.37

33495.50

-68.99

1726.58

-1.00

5.87

-0.03

0.29

-3.38

12.58

5.53

1.74

0.00

2.03

0.07

0.13

year
Analyst estimate next year EPS beginning
of the year
Analyst estimate next year EPS difference
Analyst estimate next year EPS difference
%
Analyst estimate current year sales end of
the year
Analyst estimate current year sales year
beginning of the year
Analyst estimate current year sales
difference
Analyst estimate current year sales
difference %
Analyst estimate next year sales current year
end of the year
Analyst estimate next year sales current year
beginning of the year
Analyst estimate next year sales difference
Analyst estimate next year sales difference
%
logofassets
Long-term debt/sales
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V.2 Correlation Matrix of Independent Variables
I generated the correlation matrix for all the variables used in the regressions.
The matrix shows which independent variables are strongly correlated and which are not
correlated. As Table 9 shows, the research difference percentage is strongly correlated
with the revenue difference percentage. The correlation between research spending
difference and revenue difference is .205, with .000 significance.
Table 9 Correlation Matrix for All Independent Variables
Correlations matrix
Research
LongRevenue
difference
term
difference
percentage debt/sales percentage
Research
spending
difference
in
percentage
(year over
year)
Long-term
debt/sales

Revenue
difference
percentage
(year over
year)
Log of
Assets

Gross
Margin

Pearson
Correlation
Sig. (2tailed)
N

Pearson
Correlation
Sig. (2tailed)
N
Pearson
Correlation
Sig. (2tailed)
N
Pearson
Correlation
Sig. (2tailed)
N
Pearson
Correlation

X

Log of
Assets

Gross
Margin

-.011

.205

-.018

-.005

.317

.000

.117

.651

7898

7767

6650

7898

7881

-.011

X

-.019

.221

-.004

.122

.000

.746

.317
7767

7767

6562

7767

7753

.205

-.019

X

-.012

-.026

.000

.122

.336

.033

6650

6562

6650

6650

6647

-.018

.221

-.012

X

.073

.117

.000

.336

7898

7767

6650

7898

7881

-.005

-.004

-.026

.073

X

Sig. (2tailed)

.651

.746

.033

.000

N

7881

7753

6647

7881

.000

7881

Notes : Correlation Matrix between all independent variables used in regression.

35
In Table 10, the correlation matrix shows the results generated for the companies
with market capitalization greater than or equal to $10 billion. As with Table 9’s results,
the research difference percentage is strongly correlated with the revenue difference
percentage. The correlation between research spending difference and revenue difference
is .586, with .000 significance. This is much higher than the correlations for the sample at
large, indicating that large companies exhibit a very strong relationship between R&D
and sales changes. All other independent variables are negatively correlated to the
research difference percentage.
Table 10 Correlation Matrix for Large Size Firms

Research
spending
difference
in
percentage
(year over
year)
Long-term
debt/sales

Revenue
difference
percentage
(year over
year)
Log of
Assets

Gross
Margin

Correlations Matrix for market value >= 10 billion
Research
LongRevenue
difference
term
difference
Log of
percentage debt/sales percentage Assets
Pearson
X
-.122
.586
-.321
Correlation
Sig. (2.013
.000
.000
tailed)
N
424
412
413
424
Pearson
Correlation
Sig. (2tailed)
N
Pearson
Correlation
Sig. (2tailed)
N
Pearson
Correlation
Sig. (2tailed)
N
Pearson
Correlation

-.122

X

.013

Gross
Margin
-.095
.051
424

.030

.176

-.076

.555

.000

.121

412

412

401

412

412

.586

.030

X

-.366

.116

.000

.555

.000

.018

413

401

413

413

413

-.321

.176

-.366

X

-.085

.000

.000

.000

424

412

413

424

424

-.095

-.076

.116

-.085

X

.079
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Sig. (2.051
.121
.018
.079
tailed)
N
424
412
413
424
424
In Table 11, the correlation matrix illustrates the results for companies with less
than $10 billion and more than $1 billion in market capitalization. Similar to large
companies, the research difference percentage is strongly correlated with the revenue
difference percentage. The correlation between research spending difference and revenue
spending is .627.
Table 11 Correlation Matrix for Medium Size Firms
Correlations Matrix for Market value > 1 billion and < 10 billion
Research
LongRevenue
difference
term
difference
Log of
Gross
percentage debt/sales Percentage Assets
Margin
Research
Pearson
X
-.092
.627
-.201
-.069
spending
Correlation
difference
Sig. (2.000
.000
.000
.004
in
tailed)
percentage N
(year over
1716
1693
1580
1716
1716
year)
Long-term Pearson
-.092
X
-.095
.298
-.017
debt/sales
Correlation
Sig. (2.000
.000
.000
.487
tailed)
N
1693
1693
1558
1693
1693
Revenue
Pearson
.627
-.095
X
-.269
-.107
difference
Correlation
percentage Sig. (2.000
.000
.000
.000
(year over
tailed)
year)
N
1580
1558
1580
1580
1580
Log of
Pearson
-.201
.298
-.269
X
-.023
Assets
Correlation
Sig. (2.000
.000
.000
.336
tailed)
N
1716
1693
1580
1716
1716
Gross
Pearson
-.069
-.017
-.107
-.023
X
Margin
Correlation
Sig. (2.004
.487
.000
.336
tailed)
N
1716
1693
1580
1716
1716
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In Table 12, the correlation matrix shows results for companies with market
capitalization that is less than or equal to $1 billion. Although these results show that the
research difference percentage is correlated with revenue difference percentage, the
correlation is not as strong as it is for companies with more than $1 billion in market
capitalization. The correlation between research spending difference and revenue
spending is .167 although this is much lower than in large companies. All other
independent variables are not significant at normal levels.
Table 12 Correlation Matrix for Small Size Firms
Correlations Matrix for Market value <= 1 billion
Research
LongRevenue
difference
term
difference Log of Gross
percentage debt/sales Percentage assets Margin
Research
Pearson
X
-.016
.167
.001
-.016
spending
Correlation
difference in
Sig. (2.294
.000
.969
.280
percentage (year tailed)
over year)
N
4473
4399
3894
4473
4458
Long-term
Pearson
-.016
X
-.010
.190
-.005
debt/sales
Correlation
Sig. (2.294
.536
.000
.727
tailed)
N
4399
4399
3849
4399
4387
Revenue
Pearson
.167
-.010
X
.009
-.026
difference
Correlation
percentage (year Sig. (2.000
.536
.566
.100
over year)
tailed)
N
3894
3849
3894
3894
3891
Log of Assets
Pearson
.001
.190
.009
X
.095
Correlation
Sig. (2.969
.000
.566
.000
tailed)
N
4473
4399
3894
4473
4458
Gross Margin
Pearson
-.016
-.005
-.026
.095
X
Correlation
Sig. (2.280
.727
.100
.000
tailed)
N
4458
4387
3891
4458
4458
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I analyzed sales estimate forecasts and research spending, then followed the same
procedure for the EPS estimates. Within the sales tests, I analyzed both the current year
and the following year. The tests were initially focused on all IT companies; I then drilled
down into market size and industry segments.
V.3 Hypothesis 1: A change in R&D expenditure impacts analysts’ sales
estimate forecasts for the current year.
To test this hypothesis, a correlation test was performed between the R&D
spending difference percentage and the analysts’ sales estimates difference percentage for
the current year (see Table 13).
Table 13 Correlation R&D and Analyst Sales Estimate
Years

Sector description

Pearson

Sig

N

Correlation
Current year estimate

All IT companies

.153

.000

6830

Next year estimate

All IT companies

.183

.000

6690

Notes: Correlation of Analyst Sales estimate percentage difference (dependent
variable) with R & D expenditure percentage difference (independent variable)

As Table 13 shows, there is a positive correlation between R&D expenditure and
analysts’ sales estimates for the current year. The Pearson correlation is .153, with .000
significance (Table 13); the number of records used for the current year analysis was
6,830. Based on the correlation results, Hypothesis 1 is supported.
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V.4 Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the next year.
To test this hypothesis, I performed correlation analysis for the next year (Table
13). The results show a correlation between R&D expenditure and analysts’ sales
estimates. The Pearson correlation is .183, with .000 significance; the number of records
used for the next year analysis was 6,690. Based on the correlation results, Hypothesis 2
is also supported.
Although the correlation tests support hypotheses 1 and 2, I conducted regression
tests to confirm whether changes in R&D have a major influence on changes to analysts’
sales estimates. I executed the regression tests using the five independent variables—
R&D expenditure difference percentage, gross margin, log of assets, revenue difference,
and long-term debt/sales—with the dependent variable being analysts’ sales estimate
percentage difference.
Table 14 Regression of R&D, Revenue, … with Analyst Sales Estimate
Years

R2

Sig

F

Research
spending

Gross

Margin/Sig assets

/Sig
Current

Log

Revenue

Long-

difference term

/Sig

debt/Sales

.075 .000

98.09 .221/.000

.006/.607

.095/.000

.092/.000

-.015/.242

.069 .000

87.99 .159/.000

.005/.686

.123/.000

.142/.000

-.007/.575

year
estimate
Next year
estimate
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Notes : Regression of Independent variables (R&D expenditure percentage
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term
debt/sales) with Analyst sales estimate percentage difference (dependent variable).
For the current year, the R2 value is .07; reviewing the standards coefficient beta
values shows that research spending difference has the highest influence in the regression
with .221 and .000 significance (Table 14). The revenue difference percentage standard
coefficient beta value is .092, with .000 significance, and the asset log is .095, with .000
significance, which illustrates that these independent variables also influence the
regression. Other independent variables did not prove significant in this regression.
For the next year, the regression results (Table 14) are quite similar to the current year,
with R2 at .069. In the next year results, research spending is the highest contributing
independent variable: .159, with .000 significance. Similar to the current year, in the next
year, both revenue difference and assets have a positive coefficient beta value, with .000
significance.
I further analyzed the analysts’ sales estimate percentage difference and R&D
expenditure percentage difference based on company size. For all three categories, the
current year and next year correlations are positive and the significance is .000 (see Table
15). For companies with $10 billion or more in market value for the current year, the
correlation is quite strong: .569, with .000 significance and a sample size of 421. The
sample size increases for companies with less than $10 billion in market capitalization; it
increases even more for companies with less than $1 billion in market capitalization. For
current year analyst sales estimates for companies with market capitalization of more
than $1 billion and less than $10 billion, the correlation is .350 with a significance of .000
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and a sample size of 1,685. For companies with less than $1 billion in market capital, the
current year correlation is not as strong as in other results, but still has a positive
correlation of .128, with significance of .000 and a sample size of 4,502.
The correlation for analysts’ next year sales estimate differences and the R&D
spending differences follows a pattern identical to the current year results. The
correlation is stronger for larger market capitalization companies. The next year results
reveal that, for companies with $10 billion in market value, the correlation is strong: .479,
with .000 significance. The sample size for this analysis is 421 (the sample size increases
as the market value decreases, similar to the current year pattern). For companies with
market capitalization greater than $1 billion and less than $10 billion for the next year,
the correlation is .361, with a .000 significance and a sample size of 1,674. For firms with
a market capitalization of less than $1 billion, the correlation between the analysts’ next
year sales estimates and the R&D spending difference is not as strong as in other
segments: the correlation value is .128, with .000 significance and a sample size of 3,969.
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Table 15 Correlation of R&D with Analyst Sales – Market Cap Segmentation
Years

Market value

Pearson

Sig

N

Correlation
Current year estimate

>=10 billion

.569

.000

421

Current year estimate

>1 billion &

.350

.000

1685

<10billion
Current year Estimate

=< 1 billion

.128

.000

4502

Next year Estimate

>=10 billion

.479

.000

421

Next year Estimate

>1 billion &

.361

.000

1674

.102

.000

3969

<10billion
Next year Estimate

=< 1 billion

Notes: Market cap wise correlation of Analyst Sales estimate percentage
difference (dependent variable) with R & D expenditure percentage difference
(Independent variable).
Positive correlation exists for all results in Table 15; to confirm that R&D
expenditures are the major influencer for analysts to update their sales estimate,
regression tests were performed. The regression results in Table 16 demonstrate that R2 is
65 percent, but that research spending is not significant in this regression. Other values
also are not significant in this regression, apart from the revenue difference percentage,
which had a strong coefficient value of .839. The same pattern is observed in the next
year estimate results: R2 is 37 percent, the research spending standard coefficient beta is –
.009, with .851 significance. The results show that, in the current year, the revenue
percentage difference’s standard coefficient beta is .636, with .000 significance.
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Table 16 Regression of R&D, Revenue, … with Analyst Sales Estimate (Large Size
companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current
year

.657 .000 150.2 -

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

-.024/.434

.047/.151 .839/.000

.020/.513

-.030/.468

.047/.285 .636/.000

.034/.400

.020/.583

estimate
Next year
estimate

.379 .000 47.95 .009/.851

Notes : Regression of independent variables (R&D expenditure percentage
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term
debt/sales) with Analyst Sales estimate difference percentage for companies with
market capitalization >= 10 billion.

As Table 17 shows, for companies with market capitalization greater than $1
billion and less than $10 billion, the results are similar to companies with market
capitalization greater than $10 billion. In Table 17, R2 is 49 percent with an F value of
299, but research spending is negatively correlated, with significance higher than .005.
The other variables in this regression are not significant, apart from revenue difference
percentage, which is significant with the coefficient value of .722.
The same pattern occurs in the next year estimate results (Table 17), where R2 is
65 percent; the research spending standard coefficient beta is not significant, but the
revenue percentage difference standard coefficient beta is .636, with .000 significance.
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Table 17 Regression of R&D, Revenue, … with Analyst Sales Estimate (Medium
Size companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

.493 000

299.5 -

year

Log of

Revenue

difference term

/Sig
-.055/.004

-

Long-

debt/Sales
.722/.000

.027/.181

.037/120

.009/.641

.016/.524 -.104/.000

.006/.772 .622/.000

.012/.568

estimate
Next year

.649 .000 222

estimate

Notes : Regression of independent variables (R&D expenditure percentage
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term
debt/sales) with Analyst Sales estimate difference percentage for companies with
market capitalization < 10 billion and market capitalization > 1 billion.

The pattern changes for companies with market capitalization of $1 billion or less.
In this segment, the research spending estimate difference has the highest standard
coefficient beta value of the independent values at .217, with a .000 significance. The
value for next year research spending estimate difference standard coefficient beta is
.103. In both current year and next year, the R2 is .05 and .02, respectively, and the F
values are 42.20 and 16.8, respectively, with .000 significance. Gross margin and longterm debt sales values (Table 18) are not significant, and revenue difference percentage is
significant only in the next year results section. Assets values are significant at .059 for
the current year and .068 for the next year.
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Table 18 Regression of R&D, Revenue, … with Analyst Sales Estimate (Small size
companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

.055 .000 42.20 .217/.000 .003/.863

.059/.000 .029/.079

-0.14/.381

.024 .000 16.8

.068/.000 .074/.000

-.011/.534

year
estimate
Next year

.103/.000 .001/.955

estimate

Notes : Regression of independent variables (R&D expenditure percentage
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term
debt/sales) with Analyst Sales estimate difference percentage for companies with
market capitalization < 1 billion.

Table 19 shows the analysts’ sales estimates percentage difference compared to
the R&D expenditure difference based on the IBES database’s three GIC industry
groupings: Software and Services, Technology Hardware and Equipment, and
Semiconductor. As in all three company size categories, for current year and next year
the correlation is positive for all three industry groups, with a .000 significance. For
Software and Services firms, the correlation is strong and significant with .210 and the
sample size of 2,719.
The sample size is the largest for Software and Service group. Correlation results
for Technology and Hardware companies for the current year analyst sales estimate
difference compared to R&D expenditure difference is .088, with .000 significance and a
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sample size of 2,458. The sample size for the current year Semiconductor category is
1,683—the smallest of the three sectors—yet the correlation is still significant at .136.
The next year’s results for the industry groups demonstrate the association of
analysts’ sales estimate percentage difference to R&D expenditure difference: the
correlation for Software and Services is .205, with .000 significance and a sample size of
2,657. For Technology Hardware and Equipment, the correlation with the same
constructs is .211, with .000 significance and a sample size of 2,369. As with the current
year, the sample size is lowest for the semiconductor group at 1,664, with a .120
correlation.
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Table 19 Correlation of R&D with Analyst Sales – Industry Group Segmentation
Years

Market value

Pearson

Sig

N

.210

.000

2719

.088

.000

2458

.136

.000

1683

.205

.000

2657

.211

.000

2369

.120

.000

1664

Correlation
Current year

Software and Services

estimate

(4510)

Current year

Technology Hardware and

estimate

equipment (4520)

Current year

Semiconductor and

estimate

Semiconductor
equipment(4530)

Next year

Software and Services

estimate

(4510)

Next year

Technology Hardware and

estimate

equipment (4520)

Next year

Semiconductor and

estimate

Semiconductor
equipment(4530)

Notes: Industry wise correlation of Analyst Sales estimate percentage difference
(dependent variable) with R & D expenditure percentage difference (independent
variable).
Table 20’s regression results for Software and Services shows that R2 is .08, but
the research spending standard coefficient beta is positive at .235, with significance
below .01. For the revenue difference percentage and assets log, the coefficient values are
both significant at .106 and .057. The next year results are identical to the current year
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results, where R2 is .11 with an F value of 60.11 and .000 significance. The research
spending standard coefficient beta is positive at .168, while the revenue difference and
assets log are at .229 and .130, respectively, and all three values have a significance of
less than .01. Other values are not significant in this regression.
Table 20 Regression of R&D…… with Analyst Sales Estimate (Software & Services)
Years

R2

Sig

F

Research Gross
spending

Margin/Sig assets

/Sig
Current

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

.083 .000 41.92 .235/.00

.004/.860

.057/.005 .106/.000

.001/.960

.118 .000 60.11 .168/.00

.008/.697

.130/.000 .229/.000

.007/.734

year
estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference, Ratio of
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
sales estimate percentage difference (dependent variable) for Software and Service
industry group.

In the Hardware and Equipment group, the regression results illustrate that the
standard coefficient beta for the current year is .195; for the next year, the value is the
same, with a .000 significance for both years. The analysis for current year results
showed no significance value for revenue difference, but the gross margin and asset log
values are significant, with coefficient values of .061 and .025, respectively. Results for
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the next year reveal that, apart from research spending and long-term debt/sales, all other
values are not significant.

Table 21 Regression of R&D…… with Analyst Sales Estimate (Technology
Hardware)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

.073 .000 34.48 .195/.000 .061/.004

.159/.000 .025/.227

-.001/.962

.60

.113/.000 .044/.041

.027/.218

year
estimate
Next year

.000 27.09 .195/.000 .045/.035

estimate

Notes: Regression of independent variables (R&D percentage difference, Ratio of
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
sales estimate percentage difference (dependent variable) for Technology Hardware
industry group.

Finally, in the Semiconductor Equipment group (Table 22), the results show that
research spending values are not significant. In both years, the revenue difference has a
significant standard coefficient value of .494 and .390. The R2 is 51 percent for the
current year and 16 percent for next year.
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Table 22 Regression of R&D……with Analyst Sales Estimate (Semiconductor)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

.516 .000 112.8 -

year

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

.08/.000

.117/.000 .494/.000

-.038/.092

.007/.769

.119/.000 .390/.000

.030/.217

0.43/.064

estimate
Next year

.166 .000 61.16 -

estimate

0.19/.436

Notes: Regression of independent variables (R&D percentage difference,
Ratio of gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with
Analyst sales estimate percentage difference (dependent variable) for semiconductor
industry group.

The correlation and regression results for the analysts’ sales estimate percentage
difference compared to the R&D percentage difference primarily shows a positive
correlation; a few results are negative in regression but not significant. The next few
tables show results for analysts’ EPS estimate revisions for the current year and the next
year; these results were gathered using correlation and regression tests.
For EPS, I applied a filter on the analysts’ EPS estimate percentages that were
greater than –100 percent or less than 100 percent to avoid data outliers. Also, a few
records had more than 9,000 percent positive or negative differences. These high
percentage differences were due to the EPS estimate change from a negative value at the
beginning of the year to a positive value at the end of the year, or vice versa. Filtering
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greater than –100 percent and less than 100 percent removed these extreme values and
reduced the data sample size by 5 percent.
V.5 Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the current year.
The correlation results (Table 23) for all IT companies between analysts’ EPS
estimate differences and R&D differences do not show a significant value for the current
or next year; the current year sample is 6,387 and its correlation is positive at .008, but it
is not significant (the significance value is .536).
Table 23 Correlation R&D with Analyst EPS Estimate
Years

Sector description

Pearson

Sig

N

Correlation
Current year estimate

All IT

.008

.536

6387

Next year estimate

All IT

.021

.084

6515

Notes: Correlation of Analyst EPS estimate percentage difference
(dependent variable) with R & D percentage difference (independent variable)
filtered on Analyst EPS estimate percentage > -100 and Analyst EPS estimate
percentage < 100%.

V.6 Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the following year.
The correlation results (Table 23) are positive for the next year estimate, with a
coefficient value at .021; the significance is slightly above .05, with a sample size of
6,515. Although results for the next year are better than the current year, the hypothesis
cannot be confirmed as the significance is greater than .05.
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Similar to the regression test for analyst sales estimate forecasts to confirm the
correlation results, regression tests were performed for analyst EPS estimate differences
as the dependent variable and R&D expenditure difference, gross margin, assets log,
revenue difference, and long-term debt/sales as the independent variables.
The regression results (Table 24) for all IT companies using R&D difference, gross
margin, asset logs, revenue difference, and long-term debt/sales associated with analysts’
EPS estimate differences show that research spending standard coefficient beta is
negative, but the value is not significant. The revenue difference has the highest positive
standard coefficient beta value, with .000 significance.
Table 24 Regression of R&D, Revenue, … with Analyst EPS Estimate
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current
year

.023 .000 24.15 -

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

-.011/.000

.093/.000 .124/.000

-.011/.431

-.027/.037

.131/.000 .246/.000

-.021/.116

.023/.113

estimate
Next year
estimate

.072 .000 83.86 .035/.013

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100%.

53
We removed revenue difference from the regression testing to understand
research spending’s influence on the regression in the absence of the revenue difference
variable. As Table 25 shows, the standard coefficient beta value was positive but not
significant. The next year estimate is .023, with .06 significance, and the R2 values are
quite small.
Table 25 Regression of R&D, … with Analyst EPS Estimate (Without Revenue)
Years

R2

Sig

F

Research

Gross

Log of

Long-term

spending

Margin/Sig

assets /Sig

debt/Sales

/Sig
Current year

.005

.000

7.220

.009/.493

-.017/.191

-.014/.263

-.014/.263

.010

.000

15.89

.023/.060

-.016/.197

.099/.000

-.028/.029

estimate
Next year
estimate

Notes : Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate
percentage difference(dependent variable) filtered on Analyst EPS estimate % > 100% and Analyst EPS estimate < 100%
I conducted market segmentation analysis to understand how analysts’ EPS
estimate difference is associated with R&D difference for various market sizes. As noted
earlier, the data was filtered for analysts’ EPS estimate percentage difference greater than
–100 percent and less than 100 percent. The current year results illustrate (Table 26) that
the correlation is positive and significant for large and midsized companies, with .134
and .050, respectively; for companies with less than $1 billion in market capitalization,
the correlation is not significant.
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However, reviewing results for the next year shows a standard coefficient beta
value of .223 for large, .133 for medium, and .055 for small companies, and a
significance value for all three segments of less than .01 with the next year analyst EPS
estimate as an independent variable. The current year sample sizes for large, medium,
and small companies are 404, 1,533, and 3,370, respectively, with next year sample sizes
of 405, 1,558, and 3,425, respectively.
Table 26 Correlation of R&D with Analyst EPS – Market Cap Segmentation
Years

Market value

Pearson

Sig

N

Correlation
Current year Estimate

>=10 billion

.134

.007

404

Current year Estimate

>1 billion & <10billion

.050

.051

1533

Current year Estimate

=< 1 billion

.013

.457

3370

Next year Estimate

>=10 billion

.223

.000

405

Next year Estimate

>1 billion & <10billion

.133

.000

1558

Next year Estimate

=< 1 billion

.055

.001

3425

Notes: Market capitalization wise Correlation of Analyst EPS estimate
percentage difference(dependent variable) with R & D percentage difference
(independent variable) filtered on Analyst EPS estimate percentage difference > 100% and < 100%.
Regression results for large companies (Table 27) show R2 at 11 percent for
current year and 9 percent for next year. The standard coefficient beta value for research
spending is negative and not significant; the revenue difference standard coefficient beta
is .386 and .384 for the current and next year, respectively, with less than .01
significance.
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Table 27 Regression of R&D, Revenue, … with Analyst EPS Estimate (Large Size
companies)
R2

Years

Sig

F

Research

Gross

Log of

spending

Margin/Sig assets

/Sig
Current

.119 .000 10.24 -

year

Revenue

Long-

difference term

/Sig

debt/Sales

-.048/.328 .008/.886

.386/.000

-.017/.726

-.049/.331 -

.304/.000

-.013/.815

.076/.222

estimate
Next year

.095 .000 7.975 -

estimate

.004/.953

.028/.573

Notes: Regression of independent variables (R&D percentage difference, gross
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS
estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for companies with market
capitalization > 10 billion.

The regression test (Table 28) was performed using four constructs: research
spending difference, gross margin, assets log, and long-term debt/sales; revenue
difference was not included as it had a strong influence in the previous regression test.
The results from the regression without the revenue difference reveal that R2 for the
current and next year is 2 percent and 5 percent, respectively. The research difference
standard coefficient beta for companies with market capitalization of more than $10
billion has positive values of .114 and .206 for the current and next year, respectively.
The significance for both years is less than .05 mean, while other independent variables
in this regression have significance greater than .05.

56
Table 28 Regression of R&D, … with Analyst EPS Estimate, Large Size companies
(No Revenue)
Years

R2

Sig

F

Research

Gross

Log of

Long-term

spending

Margin/Sig

assets /Sig

debt/Sales

/Sig
Current year

.022

.075

2.142

.114/.036

.035/.491

-.068/.209

.001/.986

.053

.000

5.470

.206/.000

.029/.563

-.049/.353

-.029/.563

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate
percentage difference (dependent variables) filtered on Analyst EPS estimate % > 100% and Analyst EPS estimate < 100% for companies with market capitalization
>= 10 billion.

Midsized companies regression results (Table 29) follow the same pattern as large
companies: standard coefficient beta value for research spending is negative and not
significant, whereas the revenue difference standard coefficient beta is at .386 and .384
for the current and next year, respectively, with significance less than .01. The R2 for the
current year and next year are .02 and .05 respectively. The gross margin is positive, with
a significance value of less than .05.
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Table 29 Regression of R&D, Revenue, … with Analyst EPS Estimate (Medium
Size companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current
year

.069 .000 20.42 -

Log of

Revenue

difference term

/Sig
.069/.014

.132/.000

-

Long-

debt/Sales
.284/.000

-.049/.067

.449/.000

-.003/.912

.060/.038

estimate
Next year
estimate

.150 .000 50.22 .138/.000

.116/.000

.022/.423

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for companies with market
capitalization < 10 billion and market capitalization > 1 billion.

Results without revenue difference for midsized companies indicate (Table 30)
that research spending for the current year is not significant; however, the standard
coefficient of research spending for next year is significant, with the coefficient value at
.106. The R2 is weak when regression is run without the revenue difference: the R2 is 2
percent and 3 percent for the current and next year, respectively.
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Table 30 Regression of R&D... with Analyst Sales Estimate, (Medium Size
companies)(No Revenue)
Years

R2

Sig

F

Research

Gross

Log of

Long-term

spending

Margin/Sig assets /Sig

debt/Sales

/Sig
Current year

.022

.000

8.292

.026/.329

.024/.35

-1.697/.09

-.045/.090

.039

.000

15.71

.106/.000

.031/.21

-.146/.000

.003/.921

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference, gross
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS
estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for companies with market
capitalization < 10 billion and market capitalization > 1 billion.

The last category for the regression study under the market capitalization is for
small market capitalization companies (Table 31). The regression results pattern is the
same here as for large and midsized companies: the standard coefficient values of
research spending are negative, with significance slightly above .05 for the current and
next years. As in the results for the large and midsized companies, the revenue difference
standard coefficient beta value is positive, with a significance of less than .01.
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Table 31 Regression of R&D, Revenue, … with Analyst EPS Estimate ( Small Size
companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

.014 .000 7.882 -

year

Log of

Revenue

difference term

/Sig
-.010/.578

.036/.063

-

Long-

debt/Sales
.101/.000

.028/.146

.209/.000

-.005/.787

.061/.002

estimate
Next year

.042 .000 25.76 -

estimate

.036/.056

-.042/.021

.018/.332

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for companies with market
capitalization <= 1 billion.

In Table 32, the regression results without revenue difference for small companies
demonstrate that the R2 and F values are weak for both years. The research spending
standard coefficient beta is .05, with significance less than .01; however, for the current
year, the results are not significant.
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Table 32 Regression of R&D… with Analyst EPS Estimate (Small Size companies)
(No Revenue)
Years

R2

Sig

F

Research

Gross

Log of

Long-term

spending

Margin/Sig

assets /Sig

debt/Sales

/Sig
Current year

.006

.001

4.605

.011/.521

-.015/.393

-.071/.000

.023/.189

.004

.000

3.706

.054/.002

-.022/.200

-.026/.140

-.007/.682

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate
percentage difference (dependent variables) filtered on Analyst EPS estimate % > 100% and Analyst EPS estimate < 100% for companies with market capitalization
<= 1 billion.

The next set of results is based on industry grouping. I performed correlation
tests to understand the association of R&D spending with analysts’ EPS estimate
revisions and how the results vary for different industry groups. Correlation results for
sales demonstrated a positive correlation, with a significance of less than .01. However,
reviewing the EPS results (Table 33) shows that only the Semiconductor industry
grouping has a positive correlation of .078 for the current year and .017 for the next year,
with a significance of less than .05. The other industry results show positive correlation,
but with a significance value that is greater than .05.
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Table 33 Correlation of R&D with Analyst EPS – Industry Group Segmentation
Years

Market value

Pearson

Sig

N

.014

.486

2555

.004

.844

2388

.078

.003

1475

.036

.072

2568

.017

.390

2476

.110

.000

1492

Correlation
Current year

Software and Services

Estimate

(4510)

Current year

Technology Hardware and

Estimate

equipment (4520)

Current year

Semiconductor and

Estimate

Semiconductor
equipment(4530)

Next year

Software and Services

Estimate

(4510)

Next year

Technology Hardware and

Estimate

equipment (4520)

Next year

Semiconductor and

Estimate

Semiconductor
equipment(4530)

Notes: Industry wise Correlation of Analyst EPS estimate percentage difference
(dependent variable) with R & D percentage difference (independent variable)
Analyst EPS estimate % > -100% and Analyst EPS estimate < 100%.
The next six tables (34 to 39) show regression results of analysts’ EPS estimate
percentage difference based on industry segmentation. As with other EPS tests, the data
is filtered by analysts’ EPS estimate to avoid the outliers with extreme values. The same
pattern is observed in research spending, with a negative standard coefficient beta value
for the Software and Services industry group for both years and values that are not
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significant (Table 34). The revenue difference standard coefficient is positive at .115 and
.214 for the current year and next year, respectively, with less than .01 significance. The
R2 values are 2 percent and 6 percent for the current and next years, respectively, whereas
F values are 8 and 28, respectively.
Table 34 Regression of R&D……with Analyst EPS Estimate (Software and Services
companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

.021 .000 8.46

year

-

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

-.004/.873

.094/.000 .115/.000

.001/.949

-.049/.021

.145/.000 .214/.000

.035/.114

.028/.226

estimate
Next year

.066 .000 28.89 -

estimate

.035/.139

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for software and services
industry group.

Software and Services regression results without revenue difference (Table 35)
reveal that the research spending standard coefficient for next year is positive at .044,
with significance below .05. The current year result is not significant even though values
are positive. The R2 values are quite weak for both years, and the F values are 2 and 11
for the current and next year.
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Table 35 Regression of R&D……with Analyst EPS Estimate (Software and service
companies) (No Revenue)
Years

R2

Sig

F

Research

Gross

Log of

Long-term

spending

Margin/Sig

assets /Sig

debt/Sales

/Sig
Current year

.005

.000

2.976

.015/.446

-.012/.555

.067/.001

.003/.882

.018

.000

11.20

.044/.026

-.041/.039

.115/.000

.024/.000

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate
percentage difference (dependent variables) filtered on Analyst EPS estimate % > 100% and Analyst EPS estimate < 100% for software and services industry group.

Technology Hardware and Equipment regression results reveal a negative
standard coefficient for research spending, which is significant as the values are less than
.01 for the current year and .06 for the next year. Revenue difference is positive at .150
and .260 for the current and next year, with less than .01 significance. The R2 values are
2 percent and 8 percent for the current and next year, respectively, and the F values are
11 and 35, respectively.
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Table 36 Regression of R&D……with Analyst EPS Estimate (Technology Hardware
companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

.029 .000 11.4

year

-

Log of

Revenue

Long-

difference term

/Sig

debt/Sales

-.031/.167

.103/.000 .150/.000

-.007/.763

-.002/.916

.133/.000 .260/.000

.133/.000

.067/.006

estimate
Next year

.080 .000 35.89 -

estimate

.043/.060

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst
EPS estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for technology hardware
industry group.

In Table 37, results without the revenue spending difference for Technology
Hardware and Equipment companies’ show that the standard coefficient is not
significant. In this regression, the assets log seems to have a positive standard coefficient
with a significance of less than .05. Similar to other regressions without revenue, the R2
values are 1 percent or less for both years.
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Table 37 Regression of R&D……with Analyst EPS Estimate (Technology hardware
companies) (No Revenue)
Years

R2

Sig

F

Research

Gross

Log assets

Long-term

spending

Margin/Sig

/Sig

debt/Sales

/Sig
Current year

.005

.018

2.969

.004/.851

-.022/.284

.071/.001

-.013/.539

.014

.000

8.542

.018/.362

.018/.374

.101/.000

-.07/.001

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference,
gross margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate
percentage difference (dependent variables) filtered on Analyst EPS estimate % > 100% and Analyst EPS estimate < 100% for technology hardware industry group.

Semiconductor Equipment regression results (Table 38) also have revenue
difference as a strong influence, with the standard coefficient at .306 and .284 for the
current year and the next year, respectively, and a significance of less than .01. The
research spending values are not significant for both years and the R2 value is 9 percent
for both years.

66
Table 38 Regression of R&D……with Analyst EPS Estimate (Semiconductor
companies)
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current
year

.091 .000 25.73 -

Log of

Revenue

difference term

/Sig
-.05/.062

.048/.093

-

Long-

debt/Sales
.306/.000

.081/.004

.027/.330

estimate
Next year
estimate

.090 .000 25.99 -

-.028/.286

.119/.000 .284/.000

-.029/.291

.015/.596

Notes: Regression of independent variables (R&D percentage difference, gross
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS
estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for semiconductor industry
group.

Regression results for the Semiconductor industry group without the revenue
spending difference show a positive standard coefficient value for research spending,
with a significance of less than .01. The research spending has the most influence in these
regression results, with standard coefficient values at .075 and .116 for the current and
next year, respectively. When compared with other industries, this research spending
difference for the Semiconductor group has consistent positive coefficient values for both
years.
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Table 39 Regression of R&D……with Analyst Sales Estimate (Semiconductor
companies)(No Revenue)
Years

R2

Sig

F

Research

Gross

Log of

Long-term

spending

Margin/Sig

assets /Sig

debt/Sales

/Sig
Current year

.011

.003

4.069

.075/.004

-.020/.438

.07/.010

-.031/.255

.021

.000

7.930

.116/.000

.028/.274

.088/.001

-.024/.377

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference, gross
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS
estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for semiconductor industry
group.

Analysis for R&D expenditure more than 5 percent
In their study on long-term abnormal stock returns and operating performance following
R&D increases, Eberhart, Maxwell, and Siddque (2004) used companies with research
spending greater than 5 percent as their sample data. Their study found consistent
evidence of abnormal stock returns experienced by the firm shareholders following the
R&D increases. They also observed positive long-term abnormal operating performance
following their R&D increases and suggested that the market is slow to recognize the
extent of this benefit. One of their sample criteria for selecting data for their study was a
5 percent increase in R&D. My sample data was generated by filtering the data for
research spending greater than 5 percent; I then ran correlation and regression tests
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against this generated sample data. Tables 40 to 44 show the results of these tests: the
sample sizes for R&D spending percentage greater than 5 percent are 4,241 and 4,176,
for the current year and next year, respectively, whereas the complete sample without the
filter of 5 percent was 6,830 for the current year and 6,690 for the next year. So, using
the data filter reduced the sample size by 38 percent for both the current and next year.
The correlation results (Table 40) for all companies with research spending greater than 5
percent year over year shows a positive correlation, with .201 and .167 for the current and
next year, respectively, and a significance of less than .01 for both years. The correlation
results were positive for all companies, with values at .153 and .183 for the current and
next year, respectively (Table 13).
Table 40 Correlation R&D with Analyst Sales Estimate for R&D increase > 5%
Years

Sector

Pearson

Sig

N

description

Correlation

Current year estimate

All IT

.201

.000

4241

Next year estimate

ALL IT

.167

.000

4176

Notes: Correlation of Analyst sales estimate percentage difference (dependent
variable) with R & D percentage difference (independent variable) filtered on
Analyst EPS estimate percentage > -100 and Analyst EPS estimate percentage <
100% for R&D spending difference year over year > 5%.

The regression results (Table 41) for all companies using the same constructs as
in my earlier tests demonstrates that the standard coefficient beta for research spending is
.310 and .146 for current year and next year, respectively, with a significance of less than
.01. The values of research spending difference are higher than revenue spending
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difference. The standard coefficient values for research spending for all IT companies
without the R&D spending filter were .221 and .159 for the current and next year,
respectively (Table 14).
Table 41 Regression of R&D, Revenue……with Analyst Sales Estimate with R&D
increase > 5%
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current

Log

Revenue

Long-

difference term

/Sig

debt/Sales

.130 .000 111.3 .310/.000 .078/.000

.128/.000 .098/.000

-.018/.184

.057 .000 43.15 .146/.000 .007/.654

.131/.000 .123/.000

.000/.977

year
estimate
Next year
estimate

Notes : Regression of Independent variables (R&D expenditure percentage
difference, Ratio of gross margin, Log(Assets), Revenue difference, Long-term
debt/sales) with Analyst sales estimate percentage difference (dependent variable)
filtered on R&D spending difference year over year > 5%.

The correlation results (Table 42) for analysts’ EPS estimate percentage
difference compared to R&D percentage difference shows that the correlation is not
significant in either year. These results are consistent with the results for all IT
companies without the R&D spending filter (Table 23).
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Table 42 Correlation R&D with Analyst EPS Estimate for R&D increase > 5%
Years

Sector description

Pearson

Sig

N

Correlation
Current year estimate

All IT

.005

.726

4217

Next year estimate

All IT

.016

.281

4304

Notes: Correlation of Analyst EPS estimate percentage difference (dependent
variable) with R & D percentage difference (independent variable) filtered on
Analyst EPS estimate percentage > -100 and Analyst EPS estimate percentage <
100% for on R&D spending difference year over year > 5%.

Regression results (Table 43) for analysts’ EPS estimate percentage difference
with the independent variables (research spending, gross margin, assets log, revenue
difference, and long-term debt/sales) shows that, for the current year, the correlation in
not significant, while for the next year, it is negatively correlated with a value of –.047
and a significance of less than .01. The correlation results for all IT companies (Table
24) for the current year is not significant, while the next year value is –.035. The
revenue difference (Table 43) has a positive standard coefficient with a significance of
less than .01. The R2 values are 3 percent and 8 percent and the F values are 26 and 61
for the current and next year, respectively.
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Table 43 Regression of R&D, Revenue……with Analyst EPS Estimate for R&D
increase > 5%.
Years

R2

Sig

F

Research

Gross

spending

Margin/Sig assets

/Sig
Current
year

.039 .000 26.70 -

Log

Revenue

Long-

difference term

/Sig

debt/Sales

-.008/.000

.147/.000

.141/.000

-.028/.115

-.031/.053

.157/.000

.250/.000

-.008/.625

.029/.104

estimate
Next year
estimate

.081 .000 61.09 .047/.007

Notes: Regression of independent variables (R&D percentage difference, gross
margin, Log(Assets), Revenue difference, Long-term debt/sales) with Analyst EPS
estimate percentage difference (dependent variables) filtered on Analyst EPS
estimate % > -100% and Analyst EPS estimate < 100% for on R&D spending
difference year over year > 5%.

I performed the regression again by removing the revenue difference construct for
the R&D spending difference of greater than 5 percent year over year. The research
spending standard coefficient values are not significant (Table 44), the R2 values for both
years are 1 percent, and the F values are 12 and 13 for the current and next year,
respectively.
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Table 44 Regression of R&D……with Analyst EPS Estimate (No Revenue) filtered
for R&D increase > 5%
Years

Current year

R2

Sig

F

Research

Gross

Log assets

Long-term

spending

Margin/Si

/Sig

debt/Sales

/Sig

g

.011

.000

12.21

.008/.600

-.020/.202

.110/.000

-.033/.038

.013

.000

13.86

.020/.913

-.018/.227

.115/.000

-.018/.240

estimate
Next year
estimate

Notes: Regression of independent variables (R&D percentage difference, gross
margin, Log(Assets), Long-term debt/sales) with Analyst EPS estimate percentage
difference (dependent variables) filtered on Analyst EPS estimate % > -100% and
Analyst EPS estimate < 100% for on R&D spending difference year over year > 5%.
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VI CHAPTER 6: DISCUSSION
After reviewing the correlation test results for all the IT companies, I found that R&D
expenditure has a positive correlation with analysts’ sales estimates. These results are
consistent for the current year and the next year, but the next year results show higher
correlation than the current year. The correlation results for analysts’ EPS estimates and
R&D expenditure are different than for the analysts’ sales estimate correlation results.
The results for all IT companies show that the R&D spending and the analysts’ EPS
estimates do not have a significant correlation. The next year correlation values are close
to significant, and they improved from the current year correlation values.
The regression results for all IT companies using the independent variables (R&D
expenditure difference percentage, gross margin, assets log, revenue difference, longterm debt/sales) and the dependent variable (analysts’ sales estimate percentage
difference) reveal a strong R2 for both years and a significant positive standard
coefficient beta for both years. The revenue and assets have a significant standard
coefficient beta for both years, whereas the research spending standard coefficient
reduces year over year.
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Summary of all Correlation of analyst sales and EPS with R&D
Table 45 Consolidated Correlation of R&D with Analyst Sales and EPS Revision
Current/Next

Data filtered on

Correlation

Sig

N

Supporting
Hypothesis

Sales

Current year

All IT companies

.153

.000

6860

Yes

>=10 billion

.569

.000

421

Yes

>1 billion & <10billion

.350

.000

1685

Yes

=< 1 billion

.128

.000

4502

Yes

Software and Services

.210

.000

2719

Yes

Technology Hardware and

.088

.000

2458

Yes

Semiconductor

.136

.000

1683

Yes

R&D spending percentage

.201

.000

4241

Yes

All IT companies

.183

.000

6690

Yes

>=10 billion

.479

.000

421

Yes

>1 billion & <10billion

.361

.000

1674

Yes

=< 1 billion

.102

.000

3969

Yes

Software and Services

.205

.000

2657

Yes

Technology Hardware and

.211

.000

2369

Yes

.120

.000

1664

Yes

.167

.000

4176

Yes

equipment

>5
Next year

equipment
Semiconductor and
Semiconductor equipment
R&D spending percentage
>5
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EPS

Current year

All IT companies

.008

.536

6387

Not Significant

>=10 billion

.134

.007

404

Yes

>1 billion & <10billion

.050

.051

1533

Yes

=< 1 billion

.013

.457

3370

Not Significant

Software and Services

.014

.486

2555

Not Significant

Technology Hardware and

.004

.844

2388

Not Significant

Semiconductor

.078

.003

1475

Yes

R&D spending percentage

.005

.726

4217

Not Significant

All IT companies

.021

.084

6515

Not Significant

>=10 billion

.223

.000

405

Yes

>1 billion & <10billion

.133

.000

1558

Yes

=< 1 billion

.055

.001

3425

Yes

Software and Services

.036

.072

2568

Not Significant

Technology Hardware and

.017

.390

2476

Not Significant

.110

.000

1492

Yes

.016

.281

4304

Not Significant

equipment

>5
Next year

equipment
Semiconductor and
Semiconductor equipment
R&D spending percentage
>5

The same correlation tests that were executed for analyst sales estimates and R&D
spending difference were performed for the first 10 years to observe analysts’ pattern of
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revising analyst sales and EPS estimates. Table 46 shows the results for the first 10 years
(1995–2004). The results for next 10 years (2005–2014) are captured in Table 47.
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Summary of all Correlation of analyst sales and EPS with R&D for first 10 years
Table 46 Consolidated Correlation of R&D with Analyst Sales and EPS Revision for
first 10 years (1995 – 2004)
Current/Next

Data filtered on

Correlation

Sig

N

Supporting
Hypothesis

Sales

Current year

All IT companies

.232

.000

3280

Yes

>=10 billion

.584

.000

153

Yes

>1 billion & <10billion

.370

.000

625

Yes

=< 1 billion

.208

.000

2050

Yes

Software and Services

.361

.000

1369

Yes

Technology Hardware and

.093

.000

1238

Yes

Semiconductor

.144

.000

673

Yes

R&D spending percentage

.223

.000

2063

Yes

All IT companies

.221

.000

3145

Yes

>=10 billion

.473

.000

153

Yes

>1 billion & <10billion

.385

.000

614

Yes

=< 1 billion

.138

.000

1884

Yes

Software and Services

.251

.000

1319

Yes

Technology Hardware and

.230

.000

1167

Yes

.162

.000

659

Yes

.200

.000

2010

Yes

equipment

>5
Next year

equipment
Semiconductor and
Semiconductor equipment
R&D spending percentage
>5
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Summary of all Correlation of analyst sales and EPS with R&D for last 10 years
Table 47 Consolidated Correlation of R&D with Analyst Sales and EPS Revision for
first 10 years (2005 – 2014)
Current/Next

Data filtered on

Correlation

Sig

N

Supporting
Hypothesis

Sales

Current year

All IT companies

.046

.006

3580

Yes

>=10 billion

.247

.000

268

Yes

>1 billion & <10billion

.278

.000

1060

Yes

=< 1 billion

.02

.343

2119

Not Sig

Software and Services

.009

.744

1350

Yes

Technology Hardware and

.132

.000

1220

Yes

Semiconductor

.130

.000

1010

Yes

R&D spending percentage

.070

.000

2192

Yes

All IT companies

.108

.000

3545

Yes

>=10 billion

.258

.000

268

Yes

>1 billion & <10billion

.320

.000

1060

Yes

=< 1 billion

.062

.005

2085

Yes

Software and Services

.093

.001

1338

Yes

Technology Hardware and

.201

.000

1202

Yes

.065

.039

1005

Yes

equipment

>5
Next year

equipment
Semiconductor and
Semiconductor equipment
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R&D spending percentage

.075

.000

2179

Yes

>5

VI.1 Correlation analysis
A review of all of the companies in Table 45 shows a strong correlation that
supports Hypothesis 1.

Hypothesis 1: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the current year.

The market capitalization segmentation analysis shows that correlation strength
varies depending on company size: large companies have a strong positive correlation,
midsized companies have a positive correlation, and small companies have a relatively
weak correlation. Srinivasan’s (2007) study shows the contingent effect of a firm’s
advertising and R&D expenditures on the dispersion in analysts’ forecast of earnings,
suggesting that analysts pay attention to firms’ marketing activities. Srinivasan further
adds that firms with a record of past performance, have decreased dispersion in analyst
forecasts. Typically, large and midsized companies have been in business longer and
have past experience that gives analysts more confidence when they update their
estimates. The greater the firm’s R&D expenditure, the lower the support for dispersion
in analysts’ forecast hypotheses (Srinivasan 2007).

Over the past two decades, smaller

firms have begun allocating more money to R&D (see Table 48). Hirschey et al. (2012)
discuss how the R&D share is being distributed among large, medium, and small
companies. For example, companies that Hirschey et al. ranked above 1,000 spent more
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than $1 billion on R&D in 2010. (Their data does not include financial or utility
companies.)

Table 48 Distribution of R&D Spending
(Hirschey et al)

From a comparative review of industry segmentation, the Software and Services
group has a stronger positive correlation than the Technology Hardware or
Semiconductor groups, but all three industry groups are positively correlated. In a 2014
Market Realist article, Hirschey et al. discuss the software company cost structure of IT
companies, noting that the majority of their operating expenditures consist of R&D costs
and marketing spending. With the emergence and adoption of cloud computing and open
source software, companies are finding it very difficult to maintain the high margins once
associated with the industry (Market Realist, 2014). They note that software companies
spend more on R&D investment to differentiate those products that are hard to replicate
or that are protected by intellectual property rights or patents. Patents serve as armor for
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software companies. Small companies and start-ups find patents hard to penetrate;
establishing a strong customer base makes switching costs very high and adds to the
challenges of start-ups.
As per Bloomberg’s data, between 2013 and 2014, the Internet companies Google
and Amazon increased their R&D spending by 17 and 43 percent, respectively; hardware
companies IBM and Cisco increased their R&D spending by –1.2 and 8.3 percent,
respectively; and the Semiconductor company Intel increased its R&D spending by 4.6
percent. The growth of cloud technology, which has impacted hardware companies’
revenues for the past decade, has not given analysts the confidence to update that sector’s
forecast. As other researchers have noted, past performance of companies decreases
dispersion in analyst forecasts (Srinivasan, 2007). In my analysis of companies that have
increased their R&D spending by 5 percent, I found a strong positive correlation between
R&D spending and analyst sales estimate revisions for the current year.
Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the next year.

I ran correlation and regression tests for only one year following the current year;
testing beyond that reduces the analyst forecast quality. The O'Brien study (1988)
compares consensus analyst forecasts with time-series forecasts from one- to fourquarters ahead. The analyst forecasts outperform the time-series model for one- and twoquarter-ahead forecasts, are approximately the same for three-quarter ahead forecasts, and
perform worse for four-quarter ahead forecasts. Thus, the advantage analysts gain from
firm-specific information seems to deteriorate as the time horizon for forecasting is
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extended. In valuation, the focus is more on long-term growth rates in earnings than on
next quarter's earnings. There is little evidence to suggest that analysts provide superior
earnings forecasts when those forecasts span three or five years. An early study by
Malkiel & Cragg (1980) compared long-term forecasts by five investment management
firms in 1962 and 1963 with actual growth over the following three years; they concluded
that analysts were poor long-term forecasters.

In my study, the correlation for next year is positive in all categories: for all IT
companies, it was slightly higher and, for hardware companies, the next year correlation
was higher than the current year. Another noticeable result was that, in the smaller
companies, the next year correlation is not as strong as the current year. The fact that the
analyst forecasts are not accurate over the longer term might be due to other unknown
factors, such as interest rate changes and industry-specific fluctuations. These
characteristics that are not firm-specific impact long-term analyst forecasts, which
reduces the correlation for smaller companies as they often lack the past performance
information that analysts use to update their next year estimates. Fairfield, Ramnath, and
Yohn (2009) describe how industry-specific models generate more accurate forecasts of
sales growth in firms because “firms’ sales growth depends on product demand, which
are determined at the industry level.”
Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the current year.
When reviewing the correlation between analysts’ current year EPS estimates and
R&D expenditures for all companies, the results are not significant. The companies with
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more than $10 billion market value show positive correlation, as do midsized companies
(between $1 billion and $10 million in market value), whereas the correlation is not
significant with smaller companies. This might be due to various other expenses that
impact the EPS, despite a positive correlation with the sales. For example, Company A
might increase its R&D budget and see sales increase in the current year or next year, but
expenses such as additional marketing expenses or hiring more customer service personal
to support the new products might impact the EPS and hence analysts might not change
the EPS based on R&D expenditure revisions.

Past performance of the companies can also influence analyst updates of the EPS.
Large and midsized companies with more of an R&D history might inspire analysts to
modify the EPS estimates. Semiconductor companies show a positive correlation here,
whereas Software and Services and Technology Hardware and Equipment companies do
not show significant results.
Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the following year.
The next year results for analysts’ EPS estimate forecasts are much better than the
current year results. This is because other costs associated with products are reduced as
the years go by, so analysts increase the earnings. When comparing for companies with
market cap greater than $10 billion, the correlation value is .223—much higher than the
current year value of .134. Midsized companies show a next year correlation value of
.133, compared to a current year value of .050. For small capitalization companies, the
next year results show a positive correlation compared to the current year, where the
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results were not significant. In terms of industry groups, Technology Hardware
correlation for the next year is not significant; the values are similar to the current year.
As with the current year, Software and Services results are not significant for the next
year, though the significance value is lower at .07. For the Semiconductor industry, the
correlation results for the next year are higher than the current year, but both are
positively correlated. The correlation results for R&D spending greater than 5 percent
over the previous year is not significant.
Table 49 Correlation Summary of All Tests, Year Wise View
Sales

EPS

Current year

Next year

Current year

Next year

.183

Not Sig

Not Sig

>=10 billion

.153
Ear
.569

.469

.134

.223

>1 billion & <10billion

.350

.361

.050

.133

=< 1 billion

.128

.102

Not Sig

.055

Software and Services

.210

.205

Not Sig

Not Sig

Technology Hardware and

.088

.211

Not Sig

Not Sig

equipment
Semiconductor

.136

.120

.078

.110

R&D spending percentage > 5

.201

.167

Not Sig

Not Sig

All IT companies

Notes : Correlation summary of R&D difference to Analyst sales and EPS estimate
changes.
Table 49 consolidates the summary of all correlation results. As a review of this
table shows, Hypothesis 1 and Hypothesis 2 are strongly supported. Hypotheses 3 and 4
are not significant for all tests, but Hypothesis 4 has better results than Hypothesis 3.
Givoly, Hayn, and D’Souza’s (1999) study shows that there is a stronger correlation
between firm sales and industry sales than between firm profits and industry. Sales
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increases are not impacted by other expenses that normally impact the EPS, such as
interest expenses and tax law changes. So, R&D spending has direct association with
the sales estimate, whereas for the EPS is impacted by many other factors.

It is also clear that the current year sales correlation results are stronger than the
next year’s results, but for EPS, the next year correlation results are stronger than the
current year. This phenomenon is due to the fact that R&D spending by IT might show
revenue benefit the same year as the IT industry is moving at a rapid pace. The next year
EPS results are better because the current year includes additional marketing and training
costs to launch the product; these costs reduce in the years that follow.
When I analyzed the results for first 10 years and compared them with next 10
years, I noticed a change in analyst’s behavior. The decade wise results were gathered by
running correlation tests for the analyst sales estimate difference with R&D spending
changes. Table 50 shows the results from both tests. These decade wise results are
compared against the test results from 20 years.
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Table 50 Correlation tests for analyst sales estimate with R&D decade wise
compared with 20 years data
Current/Next

Sale

Current year

Data filtered on

1995-

2005-

1995 - 2014

2004

2014

All IT companies

.232

.046

.153

>=10 billion

.584

.247

.569

>1 billion & <10billion

.370

.278

.350

=< 1 billion

.208

Not Sig

.128

Software and Services

.361

.009

.210

Technology Hardware

.093

.132

.088

Semiconductor

.144

.130

.136

R&D spending

.223

.070

.201

All IT companies

.221

.108

.183

>=10 billion

.473

.258

.479

>1 billion & <10billion

.385

.320

.361

=< 1 billion

.138

.062

.102

Software and Services

.251

.093

.205

Technology Hardware

.230

.201

.211

.162

.065

.120

.200

.075

.167

s

and equipment

percentage > 5
Next year

and equipment
Semiconductor and
Semiconductor equipment
R&D spending
percentage > 5
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The results for the decade from 1995–2004 illustrate that the next year correlation
results are lower than the current year results; however, for midsized companies, the
Technology Hardware and Semiconductor industries’ next year results are higher than the
current year. The results for 1995–2004 follow the same pattern as the 20-year
correlation results, except for IT and semiconductor companies.
My analysis also showed that the pattern for 2005–2014 was different than that
for 1995–2004. The correlation results for 2005–2014 are positive, but they are much
lower than the 1995–2004 results. Also the results indicate that the next year results for
2005–2014 are higher than current year results. Based on these results, there is strong
evidence that the R&D spending differences in the past decade (2005–2014) are
associated more with the next year analyst sales estimate revisions than those of the
current year.
VI.2 Regression Analysis
I performed regression analysis using the five independent variables (R&D
expenditure difference percentage, gross margin, assets log, revenue difference, and longterm debt/sales) and the analysts’ sales estimate percentage difference as the dependent
variable. For sales and EPS regression tests, R&D, revenue, and assets log had significant
positive standard coefficient, while gross margin and long-term debt/sales did not.

Hypothesis 1: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the current year.
I analyzed regression results to see if Hypothesis 1 is supported by R&D changes. For all
IT companies, R2 is .07 and the standard coefficient beta is positive. Segment analysis
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shows that, for market capitalization greater than $10 billion, the R2 is .65 and R&D is
not significant, but the revenue coefficient is high at .839. For midsized companies, R2 is
.50 and, similar to large companies, the revenue coefficient is high. Based on this
information, I conclude that the revenues are influencing the regression. For large
companies, the revenue changes are not volatile and R&D spending change influences
will be low. For small companies, the R&D standard coefficient is positive at .217,
whereas the revenue is not significant. Also, revenue changes are volatile for small
companies, and quite hard to predict, hence the R&D has a greater influence in analysts’
sales estimate changes.
Studying industry group segmentation shows that Software and Services and
Technology Hardware and Equipment have a positive standard coefficient for R&D
expenditure changes. Semiconductor revenue, however, shows a higher coefficient in the
regression. As the Bloomberg report showed, Software and Services companies like
Google spend more on R&D, and hence analysts are influenced to increase their sales
estimates over their revenue estimates. The same report showed that Cisco, a
Technology Hardware Company, increased its R&D by a high single digit, whereas the
Semiconductor company Intel increased it by only 4 percent. Analysts reviewing the
percentage increase of R&D spending are influenced by the industry practice of R&D
spending, and will use the latter to update their sales estimate.
For companies with abnormal R&D increases, the R&D year-over-year standard
coefficient is .310 compared to .098 for revenue difference. This result shows that, the
higher the R&D increase, the more likely analysts are to change their sales forecasts.
Based on my analysis of these regression, I conclude that Hypothesis 1 is supported by
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the regression test results, even though some results showed that revenue has a
considerable influence.
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Summary of all regression of Analyst sales and EPS estimate with R&D
Table 51 Consolidated Regression of R&D with Analyst Sales and EPS Revision
Current

Data filtered on

R2

F

R&D

Revenue Others which

/Next

are
significant

Sales Current

All IT companies

.075 98

.221

.092

>=10 billion

.65

Not

.839

Asset

year
150

Sig
>1 billion & <10billion

.50

299

Not

.722

Sig
=< 1 billion

.05

42

.217

Not Sig

Asset

Software and Services

.08

42

.235

.106

Asset

Technology Hardware and

.07

35

.195

Not sig

Asset, Gross

equipment
Semiconductor

Margin
.51

112

Not

.494

Asset

.310

.098

Asset

Asset

Sig
R&D spending percentage

.13

111

>5
Next

All IT companies

.069 87

.159

.142

>=10 billion

.38

Not

.636

year
48

sig
>1 billion & <10billion

.65

222

Not
sig

.622

91
=< 1 billion

.02

17

.103

Not Sig

Asset

Software and Services

.12

60

.168

.229

Asset

Technology Hardware and

.06

27

.195

Not Sig

Asset, Gross

equipment
Semiconductor and

Margin
.16

62

Semiconductor equipment
R&D spending percentage

Not

.390

Asset

Sig
.06

43

.146

.123

Asset

.02

24

Not

.124

Asset

>5
EPS

Current

All IT companies

year

Sig
>=10 billion

.12

10

Not

.386

Sig
>1 billion & <10billion

.07

20

-.132

.284

Asset (-),
Gross Margin

=< 1 billion

.01

8

Not

.101

Sig
Software and Services

.02

8

Not

.115

Asset

Asset

Sig
Technology Hardware and

.02

11

-.067

.150

.09

25

Not

.306

equipment
Semiconductor

Sig
R&D spending percentage
>5

.04

26

Not
Sig

.141

Asset
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Next

All IT companies

.07

83

-.035

.246

Asset

>=10 billion

.09

8

Not

.304

Asset

Gross Margin

year

Sig
>1 billion & <10billion

.15

50

-.138

.449

=< 1 billion

.04

26

Not

.209

Sig
Software and Services

.06

29

Not

.214

Asset

.260

Asset

.284

Asset

.250

Asset

Sig
Technology Hardware and

.08

36

equipment
Semiconductor and

Sig
.09

26

Semiconductor equipment
R&D spending percentage
>5

Not

Not
Sig

.08

61

Not
Sig

Hypothesis 2: A change in R&D expenditure impacts analysts’ sales estimate
forecasts for the next year.
Next year regression results (Table 51) are similar to current year regression results. The
tests that had a positive standard coefficient for the current year also had a positive
standard coefficient for the next year. The next year’s standard coefficient is slightly less
than the current year results. As I noted earlier, the O'Brien study (1988) confirms that
analyst forecasts that are more than four quarters ahead are worse than those derived
using the time-series model. Other macro and industry factors impact analysts’ sales
estimates for the next year. For example, Skyworks Solutions Company, a supplier to
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Apple, might increase its R&D spending, but if Apple revenue is expected to reduce due
to China’s slowing growth, analysts might not increase their sales estimate forecasts for
Skyworks. The next year results show that, for large companies, midsized companies,
and Technology Hardware companies, the revenue independent variable influences the
regression more than R&D expenditures. Thus, when comparing the next year values,
the revenue coefficient is slightly lower than the current year.
R&D spending increases of more than 5 percent have a positive standard coefficient for
all companies and a greater influence on regression than on revenue. Out of eight
regression tests, five show that R&D has bigger influence on the regression than the
revenue, with a positive coefficient. These results support Hypothesis 2—that R&D
expenditure change impacts analysts’ next year sales estimate forecasts.

Hypothesis 3: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the current year.
Analyst EPS regression results for all IT companies—using analysts’ EPS estimate
forecasts as the dependent variable—show that R&D spending differences have little
influence on the regression. However, regression test results show that revenue
spending’s standard coefficient is positive and has as strong influence on regression.
Further, analysts take other costs into consideration, and hence will be unlikely to modify
their EPS estimate. For example, strong competition requires more spending on
marketing the product, which impacts the bottom line and might prevent analysts from
modifying their EPS estimates. Also, companies typically hire customer service reps to
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support new products, and this cost also impacts the bottom line and might be another
reason why analysts are hesitant to update EPS estimates.
I performed regression without the revenue as a dependent variable, while
keeping the other four independent variables and the analysts’ EPS estimate revisions as
the dependent variable. The results (Table 52) show that, for large and midsized market
capitalization companies, the R&D change is significant, with a positive standard
coefficient. In the Semiconductor group, companies have a positive standard coefficient.
For all these tests, the R2 and F values are quite low. Thus, regarding Hypothesis 3, the
regression test shows that revenue is a strong influencer on analysts’ EPS estimates, but
when revenue is removed from the regression, three out of eight tests demonstrate a
positive standard coefficient. Thus, hypothesis 3 is partially supported when revenue is
not part of the regression.
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Summary of all regression of Analyst EPS estimate with R&D, without
Revenue
Table 52 Consolidated Regression of R&D with Analyst Sales and EPS Revision (No
Revenue)
Current

Data filtered on

R2

F

R&D

All IT companies

.005

7.2

Not Sig

>=10 billion

.02

2.1

.114

>1 billion & <10billion

.02

8.2

.026

=< 1 billion

.01

7.8

Not Sig

Software and Services

.00

2.9

Not Sig

Technology Hardware and equipment

.00

2.9

Not Sig

Semiconductor

.01

4.0

.07

R&D spending percentage > 5

.01

12.21

Not Sig

All IT companies

.01

15

Not Sig

>=10 billion

.05

.00

.206

>1 billion & <10billion

.04

15

.106

=< 1 billion

.00

3.7

.054

Software and Services

.01

11

.044

Technology Hardware and equipment

.01

8.5

Not Sig

Semiconductor and Semiconductor

.02

.00

7.9

.01

13.8

Not Sig

/Next
EPS

Current year

Next year

equipment
R&D spending percentage > 5
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Hypothesis 4: A change in R&D expenditure impacts analysts’ EPS estimate
forecasts for the following year.
EPS next year regression test results (Table 51) are similar to the current year
regression results: revenue difference has more influence in the regression for all eight
tests and R&D is not significant; where it is significant, the values are negative standard
coefficients. The same reasons as for current year analysts’ using revenue over R&D
apply for the next year test results. I reran regression without revenue, keeping other
independent variables, to understand the behavior of R&D change on the regression.
Results show that, in three out of eight tests, the R&D differences had a positive standard
coefficient for the next year. Five out of the eight tests had a positive standard
coefficient, while the next year results had a higher coefficient than the previous year’s
values.
Large capitalization company values were .206, while midsized capitalization
company values were .106. The current year values were .114 for large companies and
.026 for midsized companies. I also found a significant increase in the coefficient in the
next year results. The values of small companies and software companies were not
significant in the current year, but have a positive standard coefficient in the next year.
As stated in the correlation analysis, analysts modify EPS estimates based on R&D
differences in the: previous year. Analyst are recognizing that R&D spending in large
companies is based on past R&D investment experiences and their impact on the
company’s financial results.
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Regression summary of R&D difference to Analyst sales and EPS estimate changes.
Table 53 Regression Summary of All Tests, Year Wise View
Sales

EPS

Without revenue
difference

Current

Next

Current

Next

Current

Next

year

year

year

year

year

year

.159

Not Sig

-.035

Not Sig

Not Sig

>=10 billion

.221
ear
Not Sig

Not sig

Not Sig

Not Sig

.114

.206

>1 billion & <10billion

Not Sig

Not sig

-.132

-.138

.026

.106

=< 1 billion

.217

.103

Not Sig

Not Sig

Not Sig

.054

Software and Services

.235

.168

Not Sig

Not Sig

Not Sig

.044

Technology Hardware and

.195

.195

-.067

Not Sig

Not Sig

Not Sig

equipment
Semiconductor

Not Sig

Not Sig

Not Sig

Not Sig

.07

7.9

R&D spending percentage

.310

.146

Not Sig

Not Sig

Not Sig

Not Sig

All IT companies

>5

Table 53 shows all the results, summarizing all of the regression tests in a single
snapshot. The regression results are similar to correlation in terms of sales estimate
revisions: five out of the seven tests are supported in the current and next year results.
The pattern of R&D impact on analysts’ sales estimates reduces in the next year, which
matches the pattern observed in analysts’ sales estimate revisions and R&D difference
correlation results. Based on the earlier observations, I conclude that hypotheses 1 and 2
are supported. Summarizing analysts’ EPS estimates shows no significance for R&D
difference in the regression, and revenue difference is the primary influencer on the
estimates. When I remove revenue difference from the regression, large, midsized, and
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Semiconductor companies’ R&D change results are significant; the past R&D
performance of these companies influence analysts’ to update their EPS estimates. A
January 2009 survey conducted by the US National Science Foundation and the US
Census Bureau found that companies with fewer than 500 employees accounted for 11
percent of worldwide sales for all US companies, but 19 percent of research spending.
Companies with more than 25,000 employees accounted for 42 percent of global sales,
but just 36 percent of research outlays. These very small companies (those with 5 to 24
employees) spent $3 billion—that is, at least 50 percent more than all other small firms
(those with fewer than 500 employees)—in payments to others to do research. The tinest
of the companies also had the most research ($5 billion worth) paid for by
others (Courtney Rubin, Inc., 2009).
Even though the large companies with more than 25,000 employees are smaller in
number, they account for 36 percent of the total research spending. Companies gradually
increase their research spending; for large companies, this creates a trail of past
performance that lets analysts revise their estimates based on R&D spending over time.
The next year results for EPS estimate revision impact shows five positive coefficients,
and their values are higher than the current year, which follows the pattern of EPS
correlation results. Regression patterns match correlation patterns when the results are
compared year over year. The current year results in sales estimate regression are
stronger than the next year results; however, for EPS estimates, the regression without
revenue difference shows stronger next year results than current year results. R&D
revisions that impact analysts’ sales revisions for IT companies are seen in the same year,
while analysts’ EPS estimate changes due to R&D revisions are seen in the next year due
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to the additional costs involved in launching a new product. Table 54 shows the results of
the Hirschey et al. study that compared research spending changes from 1976 to 2010.
Although smaller companies are spending more, the number of firms that spent less than
$25 million increased by 53 percent, while large ($250 million or more in spending) and
midsized companies (between $25 and $250 million) showed 490 percent and 134
percent growth, respectively.
Table 54 Number of R&D Firms
(Hirschey et al, 2012)

Table 55 shows the results of Hirschey et al.’s study in terms of R&D spending to
total earnings as reported by the top 100 R&D spenders, the next 100 largest, and so on.
(Again, these figures do not include financial or utilities companies.)
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Table 55 Earnings of R&D Firms
(Hirschey et al, 2012)

VI.3 Summary of Hypothesis Results
Table 56 Summary of Hypothesis Results
Correlation

Regression

Regression without
Revenue difference

Hypothesis 1

Supported

Supported

Hypothesis 2

Supported

Supported

Hypothesis 3

Supported

Not Significant

Partially Supported

Hypothesis 4

Supported

Not Significant

Supported
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Table 56 summarizes the hypothesis findings in the correlation and regression
tests. Hypotheses 1 and 2 are supported by both correlation and regression. Hypotheses
3 and 4 are supported by correlation testing. During regression testing, when the revenue
difference variable is removed, Hypothesis 4 is supported and Hypothesis 3 is partially
supported.
VI.4 Contribution to Practice
This study finds a statistically significant relationship between the changes in
R&D spending and analysts’ sales estimate forecasts. Although there is strong belief in
the industry that R&D spending impacts company revenues, analysts recognize the
benefits of R&D differently based on a company’s size and IT sector. Further, analysts
update their sales and EPS estimates in different ways for the current and the next year.
This research breaks down the relationship between the R&D spending and analysts’
sales estimate revisions and EPS estimate revisions using 20 years’ worth of IT sector
data. Practitioners, company leaders and chairmen, and chief executive officers (CEOs)
can review this report when making decisions about R&D spending. Previous studies
have proven a strong correlation between analyst revisions of company revenue and
earnings to stock price movement. Top managers at all firms are interested in increasing
their stock price.. This research paper will help the CEOs and chief financial officers
(CFOs) of IT companies make decisions about how to allocate R&D expenditures for
their company in a way that benefits them in both the short and long term.
As these research results show, a strong correlation exists between R&D spending and
analysts’ sales estimates, and how the EPS revisions increase next year over current year
based on R&D spending. The economic significance of the estimates is large. I find that
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analysts typically adjust their EPS estimates in a range of about 5-30 percent of the
percentage change in R&D expenditures. So if R&D expenditures were to change by
50%, for example, analyst EPS revisions would change by about 2.5 to 15 percent. This
understanding is especially important for small companies, since they have fewer market
participants who follow their stock.
Companies that are planning to diversify from one industry to another can also
benefit from this research, including hardware companies that are planning to move into
the software business. IBM, which is a primarily a hardware company, has moved into
the software industry over the past two decades. Companies wanting to take the path of
IBM or vice versa can review this report to get an overview of their R&D allocation to
different segments.
Finally, companies that are growing in market capitalization can benefit from this
study, which can help them understand how R&D spending impacts the analysts’
estimates in sales and earnings.
VI.5 Contribution to Theory
My study fills a gap in the literature by examining how analysts use R&D
expenditures to adjust their sales and EPS estimates. In theory, increased R&D should
lead to increased sales, which should translate to increased earnings. Academic research
has traditionally focused on R&D spending and its impact on earnings. For example,
Chan et al.’s study (2001) focused on R&D spending’s financial impact on high-tech
companies. My paper is the first to shed light on how analysts perceive the linkage
between R&D, sales, and earnings. In so doing, I provide the bridge to other strands of
the R&D and analyst literature. One of these strands is the relationship between C-level
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executives’ compensation and R&D spending. Another is a line of literature that links
analyst estimates and their impact on stock price.
While Keung (2010) has discussed the importance of analyst forecast sales and
earnings forecast revisions, little research has been done on R&D and analysts’ estimates,
and none has studied R&D spending and its impact on analysts’ sales and EPS estimates.
This research helps to fill that academic gap by examining companies’ R&D expenditures
in relation to these key analyst estimates.
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